Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8108533474130662,-2.335843772052501,0.0,0.003186367400794486,0.001,7/22,3.85%,NR2F2;ALDH1A2;PTGDS;RBP1;CYP26B1;ABCA4;RBP4
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.8271278299685857,1.9004576445466292,0.0,0.11714790362829133,0.182,7/16,8.10%,PTPRM;PTPRB;PTPRG;PTPRR;PTPRE;PTPRU;PTPRO
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.8271278299685857,1.9004576445466292,0.0,0.11714790362829133,0.182,7/16,8.10%,PTPRM;PTPRB;PTPRG;PTPRR;PTPRE;PTPRU;PTPRO
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7393578255458008,-1.8392480400382816,0.0,0.24057073875998367,0.33,5/13,6.87%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.8768427878632123,1.8326545012762525,0.0017699115044247787,0.2586003515778049,0.479,2/10,0.09%,PRDM16;MECOM
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.570608362035169,1.7989726112326316,0.0,0.32470871213152946,0.667,29/147,6.96%,RASGRF2;EPS8L2;PREX2;SPATA13;FGD5;CYTH3;CCDC88C;RAPGEF2;KALRN;DOCK9;ARHGEF28;ELMO1;DENND3;ARHGEF15;RAPGEF1;ARHGEF2;RASGRP2;ABR;RAPGEF5;HERC2;CYTH1;NUCB2;BCR;RAPGEF4;RAPGEF6;FGD6;SMCR8;MADD;RAB3GAP2
prerank,BMP receptor binding (GO:0070700),-0.7393621211297395,-1.7962890357182089,0.004672897196261682,0.2644684942659424,0.474,5/12,6.87%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,FMN binding (GO:0010181),0.8478633613614235,1.7687878415708265,0.0051635111876075735,0.3952891088403589,0.807,2/11,0.41%,NOS1;NOS3
prerank,platelet-derived growth factor binding (GO:0048407),-0.746875210983325,-1.7607775672484864,0.005141388174807198,0.290490494705764,0.611,7/11,2.71%,COL1A2;COL3A1;COL1A1;PDGFRB;COL5A1;PDGFRA;COL6A1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.6068284097879244,-1.753400136533697,0.017341040462427744,0.25023605320906034,0.638,5/21,2.89%,PDE1A;PDE5A;PDE7B;PDE3A;PDE8B
prerank,amino acid binding (GO:0016597),0.6889217292516729,1.752923874060778,0.007062146892655367,0.4045896478006133,0.873,7/31,11.15%,NOS1;NOS3;CASTOR1;ASS1;GRIN2B;CAD;GRIN3A
prerank,P-type ion transporter activity (GO:0015662),0.8207347667436357,1.7475323012133341,0.0,0.3717900865594972,0.886,5/12,4.35%,ATP2A3;ATP2B4;ATP2B2;ATP2C1;ATP7A
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.570343227910103,-1.735650669124577,0.006493506493506494,0.24605837150579643,0.689,8/27,6.71%,SLC22A8;SLC26A7;SLC39A14;SLC26A2;ANO1;SLC39A8;SLC22A6;SLC5A5
prerank,carboxylic acid binding (GO:0031406),0.6515528362590439,1.7220795792917851,0.006868131868131868,0.4384539795548497,0.952,8/38,11.39%,NOS1;NOS3;CASTOR1;GLUD1;GRIN2B;CAD;GRIN3A;HIF1AN
prerank,retinoic acid binding (GO:0001972),-0.7104636377320119,-1.7202991124454228,0.01507537688442211,0.2468676076710776,0.738,2/12,2.53%,NR2F2;CYP26B1
prerank,cadherin binding (GO:0045296),0.5203582859427158,1.715486601689297,0.0,0.42160282882546896,0.961,96/315,16.60%,PTPRM;PTPRJ;EPS8L2;PTPRB;CDH13;LIMA1;EHD4;CD2AP;MRTFB;DOCK9;BMPR2;F11R;FASN;COBLL1;FLNB;ESYT2;MACF1;DAB2IP;STXBP6;TMPO;CBL;LRRFIP1;CEMIP2;IQGAP1;PPFIBP1;SWAP70;PACSIN2;CDC42EP1;ACVR1;STK24;PROM1;SLK;EHD1;PDLIM5;SHTN1;TAGLN2;STK38;CSNK1D;FNBP1L;MYH9;SH3GL1;STAT1;PLEC;BSG;FXYD5;RANGAP1;CTNNA1;CCT8;NUMB;TJP2;GPRC5A;PCMT1;PTPRO;CDH3;CDH15;APC;CDH12;RTN4;TJP1;UNC45A;TRIM25;HNRNPK;EPN2;PTPN1;RPL34;RANBP1;CDH2;PCBP1;EEF2;KLC2;MARK2;WASF2;GCN1;CTNNA2;CAPG;TMOD3;TBC1D10A;SPTAN1;CTNNB1;RPL23A;RAN;VAPA;EIF2A;CHMP2B;EVPL;DDX6;UBFD1;RACK1;PKN2;PAK2;CDH22;AHSA1;NCK1;ANK3;ATXN2L;ARFIP2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.6795907972682813,1.7043113014871767,0.010432190760059613,0.42795441640808163,0.975,6/29,8.40%,PTPRJ;ACE;DUSP1;GCH1;DUSP16;NBR1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6456023895722719,1.6913257087287366,0.008356545961002786,0.4445522106754473,0.984,3/35,3.12%,BMX;FYN;FES
prerank,solute:anion antiporter activity (GO:0140323),-0.6626232368646572,-1.689368635584691,0.005555555555555556,0.28876454569700033,0.824,6/14,18.61%,SLC7A11;SLC26A7;SLC26A2;SLC4A2;SLC4A3;SLC26A6
prerank,chemoattractant activity (GO:0042056),0.6698265241854002,1.6833648111148205,0.016105417276720352,0.44015529765733524,0.989,3/26,3.90%,VEGFC;PDGFB;VEGFD
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.7724817620285916,1.683128054201488,0.0176,0.407119813183797,0.989,3/12,3.90%,VEGFC;DAB2IP;VEGFD
prerank,monocarboxylic acid binding (GO:0033293),-0.6094533412576466,-1.6759680160008974,0.0215633423180593,0.29373586891027686,0.855,3/18,6.68%,NR2F2;CYP26B1;NAPEPLD
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7907446342845432,1.6651853061097404,0.009933774834437087,0.448939654390577,0.995,2/11,1.44%,KCNQ1;KCNE3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5615709571780587,-1.6580612294163342,0.026785714285714284,0.3102459725906898,0.902,5/23,2.89%,PDE1A;PDE5A;PDE7B;PDE3A;PDE8B
prerank,receptor antagonist activity (GO:0048019),0.7205475662985479,1.6549478923036887,0.023474178403755867,0.46126784515770364,0.996,2/17,4.83%,DKK2;WFIKKN1
prerank,transferrin receptor binding (GO:1990459),-0.6967297098812845,-1.6540997237103265,0.019704433497536946,0.2895732071206868,0.91,5/10,16.25%,RGMA;SNX1;CD81;CHUK;SNX2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7255858985640553,-1.6454068300625702,0.01744186046511628,0.2840292496985974,0.916,3/10,5.85%,SLC6A13;SLC6A12;SLC6A1
prerank,growth factor activity (GO:0008083),0.5678578864024285,1.6429116669909412,0.0024600246002460025,0.4842072842395506,0.998,4/74,0.89%,VEGFC;JAG1;JAG2;PDGFB
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.616556325145262,-1.6291301205963942,0.034210526315789476,0.2965772734585637,0.941,4/15,6.31%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.7265285025254387,1.6183945453948672,0.031545741324921134,0.5644372998834443,1.0,2/14,1.44%,KCNQ1;KCNE3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.7470770647627485,1.6171232273861216,0.028481012658227847,0.5386967223552686,1.0,1/12,0.10%,ENTPD1
prerank,anion:anion antiporter activity (GO:0015301),-0.6090623121235458,-1.6139108451409743,0.014164305949008499,0.3112777487014233,0.964,7/17,18.61%,SLC26A7;SLC26A2;SLC25A4;SLC19A1;SLC4A2;SLC4A3;SLC26A6
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.6861043285504765,-1.6116203457101086,0.02358490566037736,0.29626136010942516,0.969,7/10,24.67%,HAT1;USP22;ATF2;MSL3;NAA60;NAA40;NAA50
prerank,voltage-gated calcium channel activity (GO:0005245),-0.471887193185387,-1.6087280242029434,0.018050541516245487,0.28537903033365614,0.972,9/37,11.67%,CACNA2D3;CACNA1C;ITGAV;CACNG4;CACNA2D1;CACNA1G;NCS1;CACNB1;CACNB2
prerank,calcium-activated potassium channel activity (GO:0015269),0.7701785565503011,1.6046952807636332,0.019639934533551555,0.56693547595609,1.0,2/11,2.78%,KCNN4;KCNN3
prerank,peptidoglycan binding (GO:0042834),0.7842583088841122,1.6021034299531614,0.026455026455026454,0.5509840197621088,1.0,2/10,1.74%,NOD1;NOD2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6917643215418227,1.59939910003348,0.028081123244929798,0.5363665723917738,1.0,2/19,0.68%,AFAP1L2;EFNA5
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6748095484366616,-1.598172968049287,0.01278772378516624,0.2922711117826786,0.98,4/11,5.85%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.5542687540742752,1.5972984033445181,0.012106537530266344,0.5204265790382449,1.0,16/71,10.31%,PTPRM;PTPRJ;PTPRB;PTPRG;PTPRR;PTPN14;DUSP1;PTPRE;CDC25C;DUSP3;PTPN12;PTPRU;PTPRO;DUSP11;CDC14A;PTPN1
prerank,WW domain binding (GO:0050699),0.6499887412928436,1.5924814594933348,0.0343796711509716,0.5149604582007842,1.0,7/26,10.02%,RAPGEF2;CDC25C;ENAH;TCEAL9;NDFIP2;PMEPA1;TCEAL1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.6579597067609997,1.5821186210867257,0.02735562310030395,0.5359557098568197,1.0,4/23,1.66%,PLCG2;PLCB1;CCR1;PLCB4
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.7451145963612826,1.5777718399570795,0.03099510603588907,0.5327167242502782,1.0,6/12,16.63%,ATP2A3;NOD1;CASP1;CASP8AP2;RACK1;PYCARD
prerank,growth factor receptor binding (GO:0070851),0.5267484470224212,1.5728590506731472,0.005793742757821553,0.53051211512231,1.0,12/95,7.85%,VEGFC;PTPRJ;PDGFD;HIP1;PDGFB;FYN;VEGFD;ADAM17;IL1RAP;FRS3;JAK2;PLSCR1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6114385888047302,-1.5685715933098856,0.030690537084398978,0.34572086298620175,0.994,3/14,2.95%,SLC7A11;SLC1A3;SLC25A13
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.7183265204806907,1.5623797229649092,0.02564102564102564,0.5542156239885232,1.0,7/14,16.63%,ATP2A3;NOD1;MAL;CASP1;CASP8AP2;RACK1;PYCARD
prerank,anion transmembrane transporter activity (GO:0008509),-0.6369635036257977,-1.5623411343455338,0.02406417112299465,0.3436245686435738,0.995,5/12,8.34%,SLCO2B1;SLC39A8;SLC22A6;SLC19A1;SLC4A2
prerank,sialyltransferase activity (GO:0008373),0.6488806360283537,1.5617390494431722,0.03834355828220859,0.5368526632781981,1.0,5/20,5.72%,ST6GALNAC3;ST8SIA6;ST3GAL6;ST6GALNAC2;ST6GAL2
prerank,pyridoxal phosphate binding (GO:0030170),-0.5546769295241502,-1.5610442766669912,0.028089887640449437,0.3300545565989622,0.995,13/20,34.91%,ABAT;PDXK;PYGB;PYGM;ACCS;OAT;AGXT;PLPBP;CTH;PYGL;SHMT2;SHMT1;GLDC
prerank,protein tyrosine kinase binding (GO:1990782),0.5424571467921364,1.5604226570464543,0.018270401948842874,0.5239724520561435,1.0,24/71,17.16%,CEACAM1;BMPR2;PITPNM3;PTPN14;CBL;NEDD9;CRK;ACVR1;ANGPT1;TRIM6;HYAL2;CD247;DUSP3;TJP2;PTPN1;GRM5;TOB1;DUSP22;GRB14;RACK1;NCK1;ELMO2;SOCS5;PTPN2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.566317671635133,1.5592889646599262,0.029831387808041506,0.5105250549820474,1.0,9/49,6.40%,SYT15;DOC2B;MCTP1;DYSF;ESYT2;CPNE8;ANXA3;SYT7;CPNE2
prerank,sodium channel regulator activity (GO:0017080),0.5798519318950663,1.5530769239809192,0.04700854700854701,0.5164480462992107,1.0,8/37,12.99%,NOS1;ATP2B4;CAMK2D;FXYD5;SCN1B;SGK1;NEDD4L;YWHAH
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.48424333244882733,-1.5474037200311415,0.02416918429003021,0.34812328285188016,0.996,12/29,22.39%,SLC13A3;SLC26A7;SLC1A5;SLC26A2;SLC25A13;SLC19A1;SLC1A4;SLC25A12;SLC26A6;SLC25A18;SLC25A14;SLC13A5
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.6429465180650815,1.5424318112295863,0.04084720121028744,0.5395912646115358,1.0,6/25,5.56%,FCHSD2;HIP1;HIP1R;TTPA;ARAP3;PLEKHA1
prerank,alanine transmembrane transporter activity (GO:0022858),0.7147071042527351,1.5359261415885903,0.053691275167785234,0.5472794180064801,1.0,1/12,0.19%,SLC6A6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5739315642173527,-1.5329997235308208,0.055248618784530384,0.3687978874949861,0.998,7/15,22.32%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC26A6;SLC4A8;CFTR
prerank,leak channel activity (GO:0022840),-0.5599876802657717,-1.5317899393950676,0.035422343324250684,0.35534923404512425,0.998,3/18,2.84%,KCNK2;NALCN;KCNK5
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.742183143208217,1.529416869333227,0.042833607907743,0.5569457815161969,1.0,8/11,20.93%,SGMS1;SGMS2;GNPTAB;PTDSS1;PIGF;DPAGT1;AASDHPPT;PIGO
prerank,filamin binding (GO:0031005),0.7238929896929868,1.5290501345457999,0.04878048780487805,0.5424218760055182,1.0,3/11,1.97%,NEBL;CEACAM1;FBLIM1
prerank,Notch binding (GO:0005112),0.6392126009555691,1.5281744346150468,0.05637982195845697,0.5309192681724775,1.0,6/22,6.29%,JAG1;JAG2;NOTCH4;DLL4;CUL3;ADAM17
prerank,actin monomer binding (GO:0003785),0.6258974395046135,1.5215977991244314,0.0529500756429652,0.5423460533344311,1.0,2/22,0.44%,NOS3;LIMA1
prerank,SH3 domain binding (GO:0017124),0.5349526911638923,1.518907006418097,0.030690537084398978,0.5395353002002699,1.0,16/62,7.94%,AFAP1L2;CD2AP;ELMO1;AFAP1L1;DAB2IP;CBL;CRK;EVL;ADAM15;LANCL1;AKAP5;SHANK3;ADAM12;PTPN12;PLSCR1;ENAH
prerank,phospholipase C activity (GO:0004629),0.6221412656431997,1.5163419703693999,0.045112781954887216,0.5342263480493481,1.0,4/25,1.66%,PLCG2;PLCB1;CCR1;PLCB4
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6842814626831284,1.5154155057750427,0.06796116504854369,0.5240788891985158,1.0,4/13,3.90%,PTPRJ;PDGFD;PDGFB;VEGFD
prerank,metalloendopeptidase activity (GO:0004222),-0.40077022379480337,-1.5131322987450335,0.0213903743315508,0.38922362902760427,0.999,21/76,12.31%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;ADAMTSL5;MMP14;ADAMTS17;ADAMTS5;ADAMTS10;ADAMTS3;ADAM9;ADAM19;ADAMTS15;ADAMTS9;ADAM33;MMP2;ADAMTSL4;MMP16;ZMPSTE24;MMP19
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.7042049204473546,1.50592503011833,0.04975124378109453,0.5449434513076392,1.0,3/11,11.34%,ITPR3;MCOLN1;TRPM2
prerank,microtubule plus-end binding (GO:0051010),0.6351546236384188,1.5055728065609526,0.05457227138643068,0.5333574383329557,1.0,9/20,10.99%,CLIP2;DST;TTBK2;CLIP1;CLASP1;MAPRE3;APC;CLASP2;NUMA1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.647390095765508,1.5053833400029413,0.06190476190476191,0.521586825572649,1.0,6/18,5.12%,ENG;SMAD6;SMAD7;TGFB2;FKBP1A;SMAD2
prerank,GTPase activator activity (GO:0005096),0.4556137840387561,1.5017584528174068,0.0010235414534288639,0.5223267525033586,1.0,59/313,9.63%,RASGRF2;EPS8L2;PREX2;SPATA13;FGD5;CYTH3;CCDC88C;RAPGEF2;KALRN;ARHGAP31;RGS3;DOCK9;PLCB1;ARHGEF28;RABGAP1;SIPA1L2;ELMO1;DENND3;ARHGEF15;CHN2;GNAQ;RAPGEF1;ARHGEF2;RASGRP2;ABR;RAPGEF5;HERC2;ASAP2;IQGAP1;SIPA1L3;CYTH1;RALGAPA1;ARAP3;NUCB2;BCR;RAPGEF4;TBC1D30;SGSM1;ARHGAP8;RAPGEF6;FGD6;RAP1GDS1;TBC1D8;SMCR8;MADD;LRRK2;RAB3GAP2;RGS7;RANGAP1;ARHGAP25;ARRB1;TBC1D12;TBC1D5;DENND2C;DENND6B;TBC1D1;JUN;EIF2B2;RAP1GAP2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6063781914497548,-1.4989264951977148,0.056555269922879174,0.41074400041174797,0.999,4/13,6.31%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,BMP binding (GO:0036122),0.7070220171580606,1.4979525713141135,0.07082630691399663,0.5232066261078763,1.0,3/11,3.03%,ENG;BMPR2;UCMA
prerank,NADP binding (GO:0050661),0.5808857998218159,1.497146007943439,0.06582633053221289,0.5144743673143597,1.0,2/32,0.41%,NOS1;NOS3
prerank,calcium activated cation channel activity (GO:0005227),0.6436337916010694,1.494678063624235,0.06,0.5111193958956615,1.0,2/17,3.90%,KCNN4;ANO6
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5564149546997206,1.490469994840477,0.0492676431424767,0.514041112393851,1.0,2/44,0.09%,PRDM16;MECOM
prerank,phosphotyrosine residue binding (GO:0001784),0.5605590764597614,1.4890270484875805,0.054016620498614956,0.5083915458669382,1.0,7/37,9.16%,PLCG2;SHE;CRK;SHB;BCAR3;YES1;STAP1
prerank,cAMP response element binding (GO:0035497),-0.6315958350451708,-1.4889837252696667,0.06818181818181818,0.4215400667794654,1.0,6/10,13.13%,CREB5;ATF7;CREB3L1;CREB1;ATF2;HMGA2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.6959079094491888,1.488810714040211,0.07142857142857142,0.4987681367423949,1.0,8/12,23.00%,PIK3R6;PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7080994814891668,1.4863543869055553,0.06532663316582915,0.497051759353624,1.0,5/11,9.69%,MAP4K2;DAB2IP;STK38;TCF3;MAP3K11
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.6209541132977312,1.4685096442872942,0.0832072617246596,0.5459361528646242,1.0,5/22,6.95%,DUSP12;DUSP1;PPM1F;DUSP16;DUSP3
prerank,aspartic-type peptidase activity (GO:0070001),-0.6351604373106222,-1.4617315419877248,0.07196029776674938,0.48625540050889693,1.0,2/10,5.01%,BACE2;BACE1
prerank,ephrin receptor binding (GO:0046875),0.6125301152112572,1.4597645194370727,0.07786259541984733,0.5656080182225575,1.0,7/21,10.31%,EFNA5;FYN;CBL;CRK;EFNA1;ANKS1B;PTPN1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5406487989781574,1.4529470494162378,0.06147540983606557,0.5782321144511235,1.0,8/42,9.68%,PLCG2;SHE;CRK;SHB;BCAR3;YES1;STAP1;FBXW7
prerank,CARD domain binding (GO:0050700),0.6684954122150508,1.4498751359057762,0.08986928104575163,0.5784304788128563,1.0,6/14,14.65%,NOD1;NOD2;CARD10;IRGM;CASP1;CARD19
prerank,protein kinase binding (GO:0019901),0.4362220388910459,1.444825340719447,0.0,0.5854791123094435,1.0,112/479,15.68%,PTPRJ;PLCG2;KCNQ1;TRPV4;GATA6;PTPRR;UTRN;CAVIN2;CEACAM1;MAP4K2;TRIM14;BMPR2;ACE;CCND2;RND1;ACVRL1;NOD2;CCND3;DUSP1;DAB2IP;CAV1;CAV2;RHOB;EMP2;OXSR1;IQGAP1;NEDD9;HDAC9;HDAC7;CRK;FBXO7;GCH1;TIRAP;PDE3B;ACVR1;MSN;PDLIM5;NBEA;STK38;TRIM6;PKN1;SPAG9;SIKE1;WARS1;CDC25C;SMCR8;DUSP16;CD247;ADIPOR1;CEP68;IRGM;PRKCSH;DUSP3;HNRNPA0;ELAVL1;HSPB1;MAPRE3;JAK2;TOM1L1;TJP2;BCL2L1;NBR1;APC;PTK2;TCF3;STAP1;DSP;ADAM10;TAOK2;MAP3K11;MAD2L2;NEFH;PTPN1;RAC1;ADCY4;CCDC88A;PLCG1;TPCN2;POLA1;NPM1;CADPS;EEF2;ACTB;GRM5;PRKD2;CALM3;VRK1;IRF5;PPM1D;PRC1;CTBP2;CAVIN3;DUSP22;INKA1;PIN1;HIF1A;RND2;AP1B1;CNKSR2;CDKN2D;RHOH;NSF;LYST;NELL1;KIZ;LRBA;PDCD10;NEK9;RICTOR;RACK1;PAK2;FRMD5
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.6272230329977222,-1.4417534026831742,0.0678391959798995,0.5326544171661449,1.0,4/10,14.50%,PRKAG2;PRKAR2A;PRKAR2B;PRKAR1A
prerank,MAP kinase phosphatase activity (GO:0033549),0.6779629213991554,1.439515911288391,0.10398613518197573,0.5936960584402989,1.0,3/12,6.95%,DUSP1;DUSP16;DUSP3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.684386920213403,1.4358496827929295,0.08280254777070063,0.5954780976246499,1.0,7/10,23.00%,PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,cytokine receptor binding (GO:0005126),0.4875807195793574,1.4327303080793603,0.045936395759717315,0.5962110692710408,1.0,10/83,7.75%,VEGFC;KITLG;LIFR;TGFB2;FKBP1A;VEGFD;SMAD2;ADAM17;IL1RAP;JAK2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.6002957212757528,1.4304093923101207,0.09256449165402124,0.5748730347771941,1.0,9/22,19.56%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.6002957212757528,1.4304093923101207,0.09256449165402124,0.5748730347771941,1.0,9/22,19.56%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,serotonin receptor activity (GO:0099589),0.6002957212757528,1.4304093923101207,0.09256449165402124,0.5748730347771941,1.0,9/22,19.56%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,protein tyrosine kinase activity (GO:0004713),0.46615076049197346,1.4279950134768409,0.03225806451612903,0.5737415605479644,1.0,15/108,9.01%,BMX;TEK;FLT1;TIE1;FYN;FLT4;MERTK;INSR;FES;FGFR3;ALK;LMTK2;JAK2;YES1;PTK2
prerank,actin binding (GO:0003779),0.4481974818274067,1.4271077923185524,0.020652173913043477,0.5677541553437522,1.0,19/170,4.50%,EPS8L2;MYRIP;NOS3;SYNPO;LIMA1;TRPV4;UTRN;CEACAM1;SYNE1;ABLIM1;NOD2;FLNB;MACF1;PARVB;KLHL2;ACTN4;FLII;VASH2;PDLIM5
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5789170535260222,1.4218781030286038,0.08211143695014662,0.5763093549448224,1.0,2/25,0.41%,NOS1;NOS3
prerank,death receptor activity (GO:0005035),0.6855363858369714,1.4217186995823508,0.0891089108910891,0.5681960561495926,1.0,3/11,5.70%,FAS;TNFRSF25;TNFRSF1B
prerank,protein phosphatase 2A binding (GO:0051721),0.5900805861146843,1.4200534747163724,0.09883720930232558,0.5651133033637745,1.0,12/23,19.56%,FOXO1;DAB2IP;CTTNBP2NL;MFHAS1;STRN3;GRIN3A;ARPP19;BOD1;STRN4;STRN;SMG7;PPME1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.6623179270407936,1.418501387096996,0.11867364746945899,0.5615350513556747,1.0,2/12,6.31%,CDK19;MAPK1
prerank,FAD binding (GO:0071949),-0.4758680285049165,-1.4097588796696086,0.06267806267806268,0.6196202722602429,1.0,8/24,18.47%,MICAL3;MICAL2;DDO;PRODH;CRY2;SQLE;MICAL1;NDOR1
prerank,LRR domain binding (GO:0030275),-0.5384549509667758,-1.407839564941297,0.08616187989556136,0.6061886959600354,1.0,2/14,0.42%,ROBO1;PAWR
prerank,low-density lipoprotein particle binding (GO:0030169),0.627798151730986,1.4067827185668638,0.0970873786407767,0.5916641911194704,1.0,2/16,5.40%,CDH13;PLTP
prerank,protein phosphatase binding (GO:0019903),0.46099615742547706,1.4050527716682129,0.03859250851305335,0.5887255050152068,1.0,31/117,17.76%,KCNN4;KCNQ1;CEACAM1;FLT4;ITGA1;FBXL2;ATP2B4;FOXO1;DAB2IP;IQGAP1;AKAP5;PPP1R16B;CTTNBP2NL;SHOC2;MFHAS1;HSP90B1;PTK2;STRN3;GRIN3A;ARPP19;CDC27;CTNNB1;ANK1;BOD1;RACK1;ANAPC7;STRN4;MAPK14;PPP1R16A;PPP1R9B;STRN
prerank,protein kinase C binding (GO:0005080),0.5214584854785939,1.4042951977030993,0.07506702412868632,0.5827613556682929,1.0,17/43,16.13%,TRPV4;CAVIN2;HDAC9;HDAC7;TIRAP;PDLIM5;PKN1;PRKCSH;HSPB1;DSP;ADCY4;CCDC88A;PRKD2;CAVIN3;NELL1;RACK1;NELL2
prerank,ATPase binding (GO:0051117),-0.37201487059221444,-1.4014411415784918,0.021052631578947368,0.6088702696722453,1.0,21/71,17.83%,ANK2;EGFR;TMTC4;SNTA1;SLC2A13;ABCA1;ATP1B3;ATP6V0A4;TOR1AIP1;PTPN3;ATP5IF1;SRC;TCIRG1;METTL21A;ATP1B1;PIH1D1;ATP1B2;WFS1;ZNHIT6;AR;EZR
prerank,neurexin family protein binding (GO:0042043),-0.6062118565957905,-1.4012975014213898,0.11219512195121951,0.5901417956888121,1.0,4/10,11.28%,NLGN2;CPE;SYTL5;SYTL4
prerank,fibroblast growth factor binding (GO:0017134),-0.4941303496596614,-1.3999274743092334,0.07580174927113703,0.5765393863679963,1.0,9/21,20.46%,FGFR2;THBS1;ITGAV;KL;CEP57;GPC1;FGFR4;FGFRL1;GLG1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.43536483643248,1.3948080667794862,0.022222222222222223,0.6076406130798024,1.0,33/188,12.50%,PRDM16;SOX17;SOX13;GATA6;SMAD6;SMARCA2;TAL1;HNF4A;HNF1A;SOX18;HHEX;FLI1;KLF4;MAFK;ZBTB48;MEF2C;GATA3;CEBPA;NFE2L2;NR1D1;KLF11;ARID5A;JUN;EGR1;HMGB1;DHX9;ZBTB14;ARID5B;BRCA1;HINFP;SOX10;SOX6;SUV39H2
prerank,glutamate receptor binding (GO:0035254),0.6050054251452832,1.3857161966145037,0.10889570552147239,0.6293744986721332,1.0,5/17,7.09%,HIP1;HOMER2;AKAP5;SHANK3;SHISA6
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6378931912458095,1.3840439784884675,0.1310344827586207,0.6261638872638354,1.0,5/12,4.00%,LTBP4;ENG;BMPR2;ACVRL1;ACVR1
prerank,lipoprotein particle binding (GO:0071813),0.5921104811211748,1.3813559209137152,0.11811023622047244,0.626538746542015,1.0,2/20,5.40%,CDH13;PLTP
prerank,poly(U) RNA binding (GO:0008266),-0.4969262590146154,-1.3812733612991126,0.09826589595375723,0.6203107595840796,1.0,5/20,8.81%,RBMS3;RBMS1;HNRNPH1;DAZAP1;SSB
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5873567281988731,1.3801656645913902,0.1268882175226586,0.6222347102195867,1.0,9/19,20.17%,GRID1;GRIK5;GRIK2;GABRA4;GABRA2;GABRE;GRIK1;GABRG3;GRID2
prerank,wide pore channel activity (GO:0022829),0.584630539891574,1.379384882755628,0.11323529411764706,0.6164011211981258,1.0,4/23,9.85%,GJA5;GJB1;GJA4;GJD2
prerank,AMP binding (GO:0016208),-0.5749940906092594,-1.3751180089308932,0.11380145278450363,0.6218878775664896,1.0,2/11,0.57%,PRKAG2;MPPED2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5207436048646196,1.3730076199347705,0.09803921568627451,0.6287274019178134,1.0,18/42,22.13%,IZUMO1;STXBP6;ESAM;CDC42EP1;PDLIM5;ROBO4;CD47;BSG;CD200;LRRC4C;TMOD3;NPTN;MYPN;DSCAM;PDLIM1;CNTN4;CNTN6;PAK4
prerank,phosphoric ester hydrolase activity (GO:0042578),0.5003150718380641,1.3721949539715614,0.0933852140077821,0.6237715152172731,1.0,12/49,9.96%,PTPRJ;DUSP12;ACP6;PRUNE1;SMPDL3A;APEX1;DUSP16;DUSP3;PTPRO;GDPD1;ENPP6;DUSP11
prerank,phosphatidic acid binding (GO:0070300),0.5972324082730823,1.371283048234501,0.12581699346405228,0.6189152211399249,1.0,5/19,5.83%,RAPGEF2;PACSIN2;RAPGEF6;PLTP;UQCC3
prerank,amyloid-beta binding (GO:0001540),0.46623994339774466,1.370774168996576,0.08095238095238096,0.6126425483123306,1.0,20/79,11.97%,FZD6;APBB2;APBA1;INSR;CACNA1A;ATP1A3;TGFB2;ADRB2;APOA1;FCGR2B;IAPP;PFDN6;ITGAM;VBP1;GRIA1;GRIN2B;PRNP;PFDN2;CLU;ACHE
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5367987923012268,1.3703964456736828,0.10683760683760683,0.6063094617499057,1.0,9/32,18.18%,KCNQ1;KCNE3;KCNG3;KCNC1;KCNC4;KCNA1;KCNC2;KCNH1;KCNQ3
prerank,myosin V binding (GO:0031489),0.614222618811239,1.3702864972313094,0.1321656050955414,0.599227076110559,1.0,2/15,2.20%,RAB11A;RAB6B
prerank,phospholipase inhibitor activity (GO:0004859),-0.5904886817876177,-1.3693820558284633,0.12090680100755667,0.6228168132478852,1.0,6/10,25.87%,ANXA2;ANXA1;ANXA5;ANXA4;ANGPTL3;ANXA9
prerank,cAMP binding (GO:0030552),0.6522164327198374,1.3682054949249658,0.15522875816993464,0.5988639720749167,1.0,4/11,15.92%,RAPGEF2;RAPGEF4;POPDC3;PDE4D
prerank,gap junction channel activity (GO:0005243),0.5880264302131908,1.3676163088287379,0.12351190476190477,0.594014500643294,1.0,4/22,9.85%,GJA5;GJB1;GJA4;GJD2
prerank,mRNA 3'-UTR binding (GO:0003730),-0.3563139571166807,-1.363864742777788,0.03980099502487562,0.6233510640383088,1.0,26/79,18.69%,CELF2;RBMS3;RBMS1;DDX5;CPEB1;FXR2;NUDT21;HNRNPA2B1;PUM1;CSDC2;DAZAP1;GEMIN5;YBX3;CCT5;LARP4B;CPEB2;TARDBP;CPEB3;TUT1;HNRNPU;PCBP4;ELAVL3;LARP1;RC3H1;PABPC1;ZFP36
prerank,antiporter activity (GO:0015297),0.5732413440483914,1.363358063947563,0.1375579598145286,0.6000057204360532,1.0,6/20,9.64%,SLC25A16;ATP1A3;SLC35D2;SLC35E4;CLCN3;SLC25A30
prerank,lipid phosphatase activity (GO:0042577),0.6212025473152502,1.3617721065501411,0.12258064516129032,0.5979476628177488,1.0,3/14,3.59%,SGPP2;PLPP1;INPP5K
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.420336547942541,1.3589219818868457,0.025078369905956112,0.5996152034448453,1.0,31/254,9.47%,PRDM16;MECOM;SOX17;ERG;CASZ1;NR4A2;FOXO4;FOXO1;ELK3;NR1I3;KLF7;IRF2;HNF4A;HNF1A;KLF6;SOX18;HHEX;KLF4;LEF1;MAFF;SMAD2;MEF2C;FOXF2;FOSL2;GATA3;ZBTB16;PLSCR1;CEBPA;TCF3;JUN;EGR1
prerank,cell adhesion mediator activity (GO:0098631),0.5570531614469076,1.3585242035876481,0.13456090651558072,0.5941669140712647,1.0,11/24,20.96%,BCAM;ESAM;ROBO4;CD47;BSG;LRRC4C;NPTN;MYPN;DSCAM;CNTN4;CNTN6
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.586660752448413,1.3580486357396664,0.14421553090332806,0.5888613018342714,1.0,5/18,4.00%,LTBP4;ENG;BMPR2;ACVRL1;ACVR1
prerank,transforming growth factor beta binding (GO:0050431),0.5482608001362106,1.357942836634556,0.13670133729569092,0.5826894313705956,1.0,6/23,5.46%,LTBP4;ENG;ACVRL1;ACVR1;WFIKKN1;HYAL2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5610554925990296,1.350601058851339,0.14660493827160495,0.5912642285387754,1.0,2/21,2.19%,CDK19;CDK14
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5610554925990296,1.350601058851339,0.14660493827160495,0.5912642285387754,1.0,2/21,2.19%,CDK19;CDK14
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6245574361489157,1.3455860278475282,0.15594855305466238,0.6003119023749044,1.0,1/13,0.28%,KCNQ1
prerank,pre-mRNA binding (GO:0036002),-0.43561310991839436,-1.3417862624816477,0.10191082802547771,0.6782769975007,1.0,11/28,24.92%,CELF2;DDX5;PRPF8;SRSF6;HNRNPL;HNRNPU;U2AF2;SLBP;CELF5;U2AF1;CELF1
prerank,phosphatidylinositol binding (GO:0035091),0.45827564468898485,1.3407904512551145,0.0710128055878929,0.6093737687140305,1.0,23/91,13.64%,HIP1;MYO1E;ITPR3;HIP1R;ESYT2;FES;FCHO2;ING2;PLEKHF2;EPB41;SH3YL1;SNX10;MCF2L;PASK;PITPNA;AIDA;CCDC88A;NUMA1;EXOC8;SNX11;SNX22;ZFYVE9;SNX24
prerank,clathrin adaptor activity (GO:0035615),0.611709559645751,1.340767975515891,0.14586466165413534,0.6030970135441962,1.0,5/15,9.95%,HIP1;HIP1R;AP2B1;STON1;AP2M1
prerank,disordered domain specific binding (GO:0097718),0.558231551850539,1.3405074521069493,0.15128593040847202,0.5976712954669887,1.0,7/23,12.69%,FYN;SMAD2;GAPDH;DFFB;NUMA1;CALM3;KCNA1
prerank,semaphorin receptor binding (GO:0030215),0.5568777083456808,1.3384265778194524,0.13412816691505217,0.5979711520794432,1.0,3/23,4.84%,SEMA3G;SEMA3F;SEMA7A
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.597152171762606,1.3374889746490053,0.15773353751914243,0.5949065048581681,1.0,3/15,12.80%,CCR1;CMKLR1;CX3CR1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4199652459567264,1.3349054474138882,0.048701298701298704,0.5965793449087218,1.0,25/173,11.01%,PRDM16;SOX13;KLF8;DACH1;ZFP69;ELK3;HEY1;KLF12;LRRFIP1;HHEX;HEY2;MAFK;GATA3;BCL6B;GTF2IRD1;ZBTB16;SNAI2;NR1D1;TCF3;ERF;FOXP1;JUN;ZBTB14;ZBTB34;DEAF1
prerank,chemorepellent activity (GO:0045499),0.5488315463404573,1.334811795011854,0.1465149359886202,0.5908747555257624,1.0,4/25,4.84%,SEMA3G;SEMA3F;APOA1;SEMA7A
prerank,PDZ domain binding (GO:0030165),0.46504565705896395,1.3335799869524767,0.12185929648241206,0.5886179386845974,1.0,19/61,14.28%,CCDC88C;RAPGEF2;F11R;ATP2B4;ATP2B2;TMEM88;CADM1;SNTG2;USHBP1;PLEKHA1;ADAM17;GRIA1;ACOX1;CLCN3;SLC22A5;GNG5;TBC1D10A;NSF;FZD3
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5036915400557505,-1.333017744504064,0.13165266106442577,0.672642158307716,1.0,13/17,39.73%,EPHA3;EPHA7;EPHB4;EPHB2;EPHB3;EPHA6;EFNB3;EPHB6;EPHA8;EFNA4;EPHA5;EFNA3;EPHA1
prerank,ephrin receptor activity (GO:0005003),-0.5036915400557505,-1.333017744504064,0.13165266106442577,0.672642158307716,1.0,13/17,39.73%,EPHA3;EPHA7;EPHB4;EPHB2;EPHB3;EPHA6;EFNB3;EPHB6;EPHA8;EFNA4;EPHA5;EFNA3;EPHA1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6219209139502289,1.3299011209548577,0.15993788819875776,0.593578323601175,1.0,2/13,2.51%,PIP5K1B;PIK3C2A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5158462549643067,-1.3296343204847754,0.1409921671018277,0.666935192954911,1.0,5/15,13.95%,SLC1A3;SLC1A5;SLC25A13;SLC1A4;SLC25A12
prerank,protein phosphatase 1 binding (GO:0008157),0.5716093663515467,1.325304835608578,0.15673981191222572,0.6016776904751812,1.0,3/21,6.70%,KCNQ1;PPP1R16B;SHOC2
prerank,protease binding (GO:0002020),-0.3305116652918957,-1.3218802405979904,0.027777777777777776,0.674725941433315,1.0,22/99,13.26%,COL1A2;COL3A1;COL1A1;CCBE1;BCL2;SLC2A13;ANXA2;ITGAV;PRKN;DPP4;TIMP2;NTRK2;LCOR;FAP;F3;BDKRB2;CFLAR;ADAMTSL4;SERPINE1;ATP9A;BFAR;ECM1
prerank,phosphatase activity (GO:0016791),0.4606907298760362,1.3217259842860034,0.09794437726723096,0.6066136496356265,1.0,17/73,14.30%,PTPRJ;ALPL;DUSP12;PLPP1;INPP5K;MINPP1;ACP6;PRUNE1;DUSP16;DUSP3;PTPRO;DUSP11;PLPP6;OCRL;PLPP4;DUSP28;DUSP26
prerank,poly-pyrimidine tract binding (GO:0008187),-0.45965099837860507,-1.3207950213559148,0.11343283582089553,0.6625174141403855,1.0,9/23,21.14%,RBMS3;RBMS1;HNRNPH1;DAZAP1;SSB;HNRNPU;U2AF2;PABPC1;PABPC4L
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.37373393835162433,-1.3190956251159343,0.09361702127659574,0.6532777346037968,1.0,6/53,2.95%,SLC7A11;SLC1A3;SLC7A2;SLC47A1;SLC1A5;SLC25A13
prerank,MHC class I protein binding (GO:0042288),0.6022856978727144,1.316025482102768,0.16422764227642275,0.6172437104974561,1.0,5/13,13.31%,TUBB;TUBB4B;ATP5F1A;TAP1;TAPBP
prerank,potassium ion antiporter activity (GO:0022821),-0.5028137340354212,-1.3123985966141183,0.1387434554973822,0.6613246533545238,1.0,3/15,6.74%,SLC24A3;SLC9A2;SLC9A9
prerank,calcium channel inhibitor activity (GO:0019855),0.6242280595126396,1.3110194066502288,0.19547657512116318,0.6266392961833191,1.0,3/11,7.11%,FKBP1A;MCUB;SLC30A1
prerank,insulin-like growth factor I binding (GO:0031994),-0.5165482777865392,-1.3095803826378307,0.15931372549019607,0.6560453402809691,1.0,5/13,7.17%,IGFBP5;IGFBP2;IGFBP6;ITGAV;IGFBP3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.36123319846553287,-1.3092987501825615,0.06578947368421052,0.6431716496029211,1.0,14/55,10.66%,SLC6A13;SLC16A12;SLC7A2;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC16A9;SLC38A11;SLC19A1;SLC22A4;SLC38A10;SLC16A11;SLC38A5
prerank,myosin binding (GO:0017022),0.45136725715827536,1.3078211797965595,0.13844086021505375,0.6298207601936884,1.0,14/55,17.01%,MYRIP;SHROOM4;MYBPC3;RAB11A;RAB6B;SPATA6;LMTK2;NKD2;SHROOM1;CXCR4;RAB27B;PYCARD;STXBP5;STXBP5L
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5373207699715876,-1.3074363546191314,0.15577889447236182,0.6359458270752328,1.0,2/12,3.18%,B3GALT1;B3GNT2
prerank,GTPase activity (GO:0003924),0.40766084931451424,1.3072207292492326,0.06060606060606061,0.6256569449706787,1.0,46/192,16.27%,RND1;GBP5;GNAQ;RAB11A;RAB6B;ATL2;RHOB;GNAL;GBP4;DNM3;MTG2;GCH1;NRAS;KRAS;RRAS;GNG3;ATL1;GBP3;RAB23;LRRK2;IRGM;GNAI2;RAB35;MMAA;RRAS2;RHEBL1;RRAGD;RAC1;GTPBP1;MFN1;EEF2;GBP2;GNG5;RAB19;GNB2;RHOT2;RND2;RHOH;RAN;RHEB;SRPRA;ARL8A;GNA14;GBP7;EFL1;RAB27B
prerank,nucleoside-triphosphatase activity (GO:0017111),0.4011824582500308,1.306450614897411,0.048574445617740235,0.6225940453485463,1.0,59/248,16.27%,MYO1E;RND1;GBP5;GNAQ;RAB11A;RAB6B;ATL2;RHOB;GNAL;GBP4;DNM3;MTG2;GCH1;DDX4;NRAS;KRAS;KIF26A;RRAS;GNG3;ATL1;GBP3;MYH9;THTPA;RAB23;KIF2A;LRRK2;IRGM;GNAI2;HSPA1B;MYL6;RAB35;MMAA;DHX9;RRAS2;RHEBL1;ABCG4;RRAGD;RAC1;GTPBP1;MFN1;EEF2;GBP2;GNG5;CLU;RAB19;GNB2;RHOT2;PIN1;RND2;RHOH;RAN;RHEB;SRPRA;ARL8A;KIF1A;GNA14;GBP7;EFL1;RAB27B
prerank,heme binding (GO:0020037),0.4547960372922903,1.304131589804793,0.11097099621689786,0.6238341543667382,1.0,6/65,9.34%,NOS1;NOS3;JAK2;HEBP1;NR1D1;HMOX2
prerank,N-acyltransferase activity (GO:0016410),0.5078081325583598,1.3028414486601376,0.16595744680851063,0.6220748119016839,1.0,6/32,9.21%,SATL1;CERS4;GLYAT;NMT1;CERS6;CERS5
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.468826391452034,1.3026684758230778,0.1135483870967742,0.6171289446745467,1.0,6/55,4.17%,ATP2A3;TRPV4;ATP2B4;ATP2B2;ATP2C1;ORAI1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.535115623188837,-1.30107614225646,0.16455696202531644,0.6414352661517716,1.0,6/12,17.01%,XDH;AOX1;FDX1;CIAPIN1;FXN;SDHB
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6304508498169552,1.301054153070778,0.18018018018018017,0.610986656094615,1.0,2/10,6.27%,DUSP1;DUSP16
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6304508498169552,1.301054153070778,0.18018018018018017,0.610986656094615,1.0,2/10,6.27%,DUSP1;DUSP16
prerank,SH2 domain binding (GO:0042169),0.506417143881131,1.3005620759776746,0.15549215406562053,0.6071778024082451,1.0,8/31,10.46%,AFAP1L2;TRPV4;CRK;NLK;ARHGAP5;JAK2;PTK2;CCDC88A
prerank,glycerophospholipid flippase activity (GO:0140333),0.6346425102935626,1.2998892197109375,0.18137254901960784,0.6036833347095522,1.0,4/11,12.21%,ATP10A;ABCB4;ATP11C;ATP8B1
prerank,carboxy-lyase activity (GO:0016831),0.5468232392498792,1.2974547722791998,0.17117117117117117,0.605191392427018,1.0,4/23,8.81%,AMD1;AZIN1;PCK2;ACOD1
prerank,insulin-like growth factor binding (GO:0005520),-0.5035554444798078,-1.295514342925263,0.17553191489361702,0.645494308052947,1.0,5/15,7.17%,IGFBP5;IGFBP2;IGFBP6;ITGAV;IGFBP3
prerank,I-SMAD binding (GO:0070411),0.5845009327069142,1.2952997472897607,0.19078947368421054,0.6061349113844587,1.0,5/13,14.21%,SMAD6;SMAD7;SMAD2;SMURF1;CTNNB1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.5357686621313378,-1.294835551599726,0.1486146095717884,0.6352117130172067,1.0,4/12,6.56%,SULF1;SULF2;GNS;ARSI
prerank,adenylate cyclase binding (GO:0008179),-0.5431836336063502,-1.2923317400156564,0.15980629539951574,0.6304309604200117,1.0,4/10,7.11%,ADCY5;AKAP12;ADCY2;CALM2
prerank,metallopeptidase activity (GO:0008237),-0.3207183588742593,-1.2911086839254549,0.05714285714285714,0.6219027644582095,1.0,28/113,13.76%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;PAPPA;ADAMTSL5;MMP14;ADAMTS17;ANPEP;ADAMTS5;ADAMTS10;ADAMTS3;ADAM9;ADAM19;PRPF8;ADAMTS15;ADAMTS9;ADAM33;MMP2;METAP1D;ADAMTSL4;MMP16;ZMPSTE24;MMP19;RNPEP;ADAMTS14;METAP1
prerank,kinase binding (GO:0019900),0.3904036995490008,1.2893264164050948,0.017137096774193547,0.6181374757216459,1.0,93/434,16.69%,PTPRJ;PLCG2;TRPV4;GATA6;PTPRR;UTRN;CEACAM1;TRIM14;FAS;CCND2;RND1;ACVRL1;NOD2;CCND3;ATP1A4;TTC28;DAB2IP;CAV1;CAV2;RHOB;EMP2;OXSR1;IQGAP1;HDAC7;BTG1;CRK;FBXO7;MSN;NBEA;TRIM6;BCAR3;SIKE1;WARS1;CDC25C;SMCR8;ADIPOR1;CEP68;IRGM;DUSP3;HNRNPA0;ELAVL1;HSPB1;PDE8A;MAPRE3;JAK2;TOM1L1;CEBPA;BCL2L1;WWC2;APC;PTK2;STAP1;CASP1;ADAM10;NEFH;PTPN1;RAC1;PLCG1;TPCN2;POLA1;NPM1;CADPS;EEF2;ACTB;PIK3IP1;CALM3;VRK1;IRF5;PRC1;CTBP2;INKA1;HIF1A;RND2;AP1B1;CNKSR2;CDKN2D;RHOH;NSF;LYST;CTNNB1;KIZ;LRBA;PDCD10;NEK9;RICTOR;PAK2;FRMD5;VDAC1;SGO1;PFKM;CACUL1;ESR1;DAXX
prerank,ligand-gated calcium channel activity (GO:0099604),0.5569997207865882,1.2869708179623496,0.16819571865443425,0.6198582776323889,1.0,5/19,11.34%,ITPR3;MCOLN1;GRIN2B;GRIN2C;TRPM2
prerank,chemokine receptor activity (GO:0004950),0.5277690262146817,1.285891050718112,0.16058394160583941,0.6176143303660104,1.0,4/24,14.18%,CCR1;CMKLR1;CX3CR1;CXCR4
prerank,pyrophosphatase activity (GO:0016462),0.46835471674040424,1.2848856472105206,0.15526315789473685,0.6153436387122333,1.0,11/50,14.16%,ENTPD1;ALPL;PLPP1;PRUNE1;DCPS;DHX9;ADPRM;PRUNE2;TRPM2;PLPP4;NUDT9
prerank,ion channel inhibitor activity (GO:0008200),0.494083928798856,1.2828888750011351,0.17198335644937587,0.6158614727485974,1.0,9/35,11.20%,FKBP1A;MCUB;VTI1B;STX7;CAMK2D;SLC30A1;VAMP8;SCN1B;NEDD4L
prerank,receptor ligand activity (GO:0048018),0.3961395557294422,1.2827430293696458,0.06431535269709543,0.6113545634924792,1.0,13/245,3.90%,VEGFC;SEMA3G;JAG1;JAG2;EDN1;PDGFB;KITLG;DAND5;TGFB2;SEMA3F;TAFA1;APOA1;VEGFD
prerank,double-stranded RNA binding (GO:0003725),0.4427126756345436,1.2805716572243147,0.13703703703703704,0.6118572586263256,1.0,16/70,13.22%,ADARB1;IFIH1;LRRFIP1;VIM;TLR3;MSN;MBNL1;TUBB4B;ELAVL1;ZNF346;OAS2;ADAR;DHX9;AGO4;ILF2;FXR1
prerank,GTP binding (GO:0005525),0.40465686181094584,1.2796149105290613,0.08269858541893363,0.6096804511696842,1.0,44/172,17.15%,RND1;GBP5;INSR;ATL2;RHOB;GBP4;MTG2;GCH1;NRAS;KRAS;SCG5;RRAS;RAB39A;TUBB;ATL1;GBP3;GLUD1;TUBB4B;LRRK2;MFHAS1;RAB35;MMAA;TUBA8;ARF3;EIF2B2;RRAS2;RHEBL1;RRAGD;RAC1;GBP2;RHOT2;TUBA1A;RND2;RRAD;RHOH;RAN;RHEB;ARL8A;ARL5B;GBP7;RAB27B;ARFIP2;RIT2;ARL4C
prerank,DNA-binding transcription factor binding (GO:0140297),0.4022962931573245,1.2774275897144496,0.09178228388473852,0.6107428181119141,1.0,36/189,14.48%,PRDM16;LDB2;LMO2;FOXO4;TBXT;TAL1;HNF4A;HDAC9;HDAC7;HHEX;RBBP8;HEY2;KLF4;SMAD2;MEF2C;BBS7;CHCHD2;STAT1;HSPB1;PURA;RBL1;NFE2L2;TCF3;JUN;HMGB1;DHX9;MAD2L2;CRTC1;NPM1;DMAP1;TBX20;NFATC1;CTNNB1;USF2;DUSP26;PSMC5
prerank,alkali metal ion binding (GO:0031420),-0.5105868656537704,-1.2760205846833355,0.18112244897959184,0.6557032718536161,1.0,5/13,14.95%,ATP1A2;PDXK;ADPRH;HDAC4;DRG1
prerank,protein serine/threonine kinase activity (GO:0004674),0.3892976074212243,1.2756186484972614,0.04085801838610827,0.6104849355922267,1.0,66/334,12.89%,NUAK1;CDK19;KALRN;STK10;MAP4K2;BMPR2;RPS6KA5;PLK3;ACVRL1;MAP4K3;MYLK;SBK1;CDK14;SNRK;PRKD1;MAST4;CDC42BPA;OXSR1;TRIO;MAP3K6;PKN3;CDC42BPG;ACVR1;BCR;STK24;SLK;MAP4K4;CAMK2D;STK38;CSNK1D;PKN1;STK38L;NLK;TTBK2;IRAK2;MAPK1;AKT3;UHMK1;MAST1;LRRK2;SIK2;LMTK2;TLK1;PRKAA1;STK39;PASK;PIM3;NEK7;ROCK1;SGK1;CSNK1G3;TAOK2;MAP3K11;MARK3;PRKCG;RPS6KA1;MINK1;LIMK2;NEK11;PRKD2;MARK2;VRK1;RPS6KB1;RPS6KA3;STK33;TTBK1
prerank,calcium ion binding (GO:0005509),0.390053719493717,1.2742714627743426,0.0565262076053443,0.6092289254377519,1.0,46/323,12.23%,CDH13;LTBP4;NOTCH4;SYT15;RAPGEF2;ITPR3;PITPNM3;MCTP1;DYSF;PLSCR4;EML1;ESYT2;CLGN;RASGRP2;CALML4;AOAH;CEMIP2;AGRN;IQGAP1;ANXA3;NUCB2;SYT7;SLC8A1;SPOCK2;STIM2;MEX3B;TPD52;ASAH2;EFCAB9;PPP3CA;HSP90B1;PLSCR1;CASQ1;CRACR2A;CDH3;CDH15;DSPP;CDH12;DHH;PRNP;CDH2;SPOCK1;TRPM2;PCP4;CALM3;TPM4
prerank,glucose transmembrane transporter activity (GO:0005355),0.5546746369313476,1.2723561535061794,0.1924342105263158,0.6097806086234717,1.0,2/17,3.06%,SLC2A1;SLC5A10
prerank,transcription cis-regulatory region binding (GO:0000976),0.383386621528034,1.2714759109098086,0.0364741641337386,0.6076725281380021,1.0,64/406,13.76%,PRDM16;EPAS1;SOX17;SOX13;GATA6;SMAD6;MSX1;DACH1;SMARCA2;CASZ1;ZFP69;ELK3;NR1I3;TAL1;IRF2;HNF4A;HNF1A;SOX18;HHEX;ACTN4;FLI1;KLF4;SIM2;MAFK;LEF1;ZBTB46;ZBTB48;SMAD2;MEF2C;FOXF2;FOSL2;GATA3;SETX;PURA;SNAI2;RBL1;CEBPA;NFE2L2;NR1D1;TCF3;KLF11;FOXP1;ARID5A;JUN;EGR1;HMGB1;ZBTB14;XRN2;DEAF1;NPM1;ARID5B;PHOX2A;E2F7;BRCA1;HINFP;SOX10;SOX6;ETV6;SUV39H2;ASCL4;HIF1A;TBX20;HMGB2;IKZF5
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.49505474772267466,1.2676430301710282,0.1723122238586156,0.6140168503840576,1.0,5/34,3.66%,CYTH3;FCHSD2;HIP1R;IQGAP1;ARAP3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.530134977584559,-1.2660255159954787,0.19036144578313252,0.6631058158724811,1.0,5/11,23.34%,SIL1;BAG1;BAG3;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.530134977584559,-1.2660255159954787,0.19036144578313252,0.6631058158724811,1.0,5/11,23.34%,SIL1;BAG1;BAG3;GRPEL2;BAG2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5199315824633326,-1.2643893500511951,0.21844660194174756,0.6560190100138636,1.0,3/11,7.09%,SLC25A47;SLC25A20;SLC22A4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4363022630095298,1.261264045569751,0.1568627450980392,0.6268105705003937,1.0,10/72,4.06%,KCNQ1;HIP1;PLCB1;HIP1R;STXBP6;TTPA;FLII;TIRAP;SYT7;FCHO2
prerank,transmitter-gated ion channel activity (GO:0022824),0.4986942993493126,1.2601772827645596,0.1927536231884058,0.6252497055246822,1.0,15/29,26.36%,GRID1;GRIK5;GRIK2;GABRA4;GABRA2;GABRE;GRIK1;GLRA2;GABRG3;GABRB1;GRID2;GABRB3;GRIA2;GABRA3;GRIA4
prerank,translation elongation factor activity (GO:0003746),0.5633234927303464,1.2596760086130336,0.2260596546310832,0.6221462958555699,1.0,8/14,27.21%,TUFM;GTPBP1;GTPBP2;EEF2;EEFSEC;GFM1;TSFM;EEF1A1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5980103998494697,1.2560379226547482,0.21575342465753425,0.6271778791819755,1.0,3/10,8.88%,APEX1;EXD2;FEN1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4648738422907346,-1.2549007345117185,0.15625,0.6723052091113102,1.0,8/16,22.39%,SLC13A3;SLC1A5;SLC25A13;SLC1A4;SLC25A12;SLC25A18;SLC25A14;SLC13A5
prerank,carbohydrate kinase activity (GO:0019200),-0.5278116476011916,-1.253475963853223,0.20526315789473684,0.6650506829805124,1.0,5/11,21.31%,GALK2;HK2;NAGK;GALK1;POMK
prerank,GABA-A receptor activity (GO:0004890),0.5454698288437752,1.2504852775688238,0.2078125,0.638258468261663,1.0,7/18,21.18%,GABRQ;GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.4523988947500628,-1.2487995911907892,0.1711229946524064,0.6673315459730587,1.0,17/18,54.81%,HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;DHRS11;HSD17B7;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,calcium channel activity (GO:0005262),-0.32006316150010544,-1.2486272696937353,0.05732484076433121,0.6570359227813112,1.0,16/84,11.67%,SLC24A3;CACNA2D3;CACNA1C;ANXA2;TRPC3;ITGAV;CACNG4;CACNA2D1;P2RX4;NCS1;TRPC6;TRPC4;CACNB1;TRPV2;PKD1;CACNB2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3916910834569432,-1.2484834579278206,0.13636363636363635,0.6467811893386872,1.0,14/33,15.98%,SCAF8;RRN3;ERCC5;PAF1;ERBB2;CTR9;URI1;UVSSA;GTF2B;RTRAF;HNRNPU;MAF1;PCF11;WAC
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.36048073301374317,-1.2475669022424858,0.11842105263157894,0.6394820205266437,1.0,12/48,11.48%,TRPM3;NALCN;PIEZO2;SLC12A2;SLC41A1;TRPM6;ATP6V1B2;ABCC9;TRPC6;DMAC2L;CALHM5;TRPV2
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3634417694154692,-1.247507416496546,0.10038610038610038,0.629656070591373,1.0,10/47,7.92%,SLC7A11;SLC6A13;SLC7A2;SLC47A1;PDPN;SLC1A5;SLC38A11;SLC6A1;SLC22A4;SLC38A10
prerank,histone acetyltransferase activity (GO:0004402),-0.40376508551802287,-1.2471285139385113,0.15162454873646208,0.6210148362420229,1.0,13/30,21.58%,TADA2A;CREBBP;KAT2B;TAF1;HAT1;USP22;CLOCK;ATF2;NAA60;TADA3;NAA40;MCM3AP;TAF10
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.5115017184203472,-1.2464302017663567,0.2020460358056266,0.6136332088873463,1.0,7/12,18.28%,CYFIP2;EIF4E2;NCBP1;EIF4E3;GEMIN5;LARP1;NCBP3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.4244826533866367,-1.2378719982199557,0.17857142857142858,0.6279521665685134,1.0,10/22,22.55%,IKBKE;TAB3;OPTN;PRPF8;OTUD7B;WDR81;ZRANB1;ZRANB3;RNF168;TNFAIP3
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5256791314476386,-1.2365028451719715,0.22641509433962265,0.6222475711414251,1.0,2/10,7.33%,B3GALT1;B4GALT1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.48969944803375753,1.2354700053789416,0.21910112359550563,0.6752326970946075,1.0,9/28,20.17%,GRID1;GRIK5;GRIK2;GABRA4;GABRA2;GABRE;GRIK1;GABRG3;GRID2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4078546632839771,1.2328978728737905,0.16417910447761194,0.6779926242292961,1.0,26/100,18.42%,CYTH3;FCHSD2;HIP1;HIP1R;DAB2IP;TTPA;IQGAP1;ARAP3;TECPR1;PLEKHA5;CERT1;MYO10;SNX11;SAP30L;SNX22;BTK;SNX24;PHLDA3;CLVS1;RUBCN;KIF16B;ZFYVE16;ARFIP2;KCNH1;GOLPH3L;GOLPH3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.44267699084702705,1.2288470791574804,0.19011406844106463,0.6844780222413328,1.0,7/54,6.43%,ACER2;HDAC9;GLS2;GLS;HDAC11;ASAH2;SIRT4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.5164107165103434,-1.227989004731,0.22518159806295399,0.636195964612735,1.0,4/11,20.86%,PPP1R1A;PPP1R14B;PPP1R2;PPP1R11
prerank,RNA cap binding (GO:0000339),-0.44910790201134115,-1.2262742258769976,0.23097826086956522,0.6322208118519231,1.0,9/16,18.28%,CYFIP2;EIF4E2;NCBP1;EIF4E3;GEMIN5;EIF3D;SNUPN;LARP1;NCBP3
prerank,channel activity (GO:0015267),0.45811586161023105,1.22165291696857,0.21045576407506703,0.7009635972755893,1.0,3/41,2.82%,TRPV4;AQP11;MCUB
prerank,C2H2 zinc finger domain binding (GO:0070742),0.5878673780224221,1.2192512145702281,0.2652733118971061,0.7028262355043239,1.0,2/11,4.69%,GATA2;LEF1
prerank,Toll-like receptor binding (GO:0035325),0.5799590130465134,1.2149077542386943,0.25842696629213485,0.7109416777073085,1.0,2/11,3.61%,DAB2IP;TIRAP
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.5678803552892348,1.212020124595157,0.25165562913907286,0.7143524619874831,1.0,7/12,25.55%,GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3;GABRA3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4336981797402578,1.2116585419065482,0.1994750656167979,0.71057831182208,1.0,6/53,7.85%,NOS1;NOS3;CYB5R1;ETFDH;ETFA;ACOX1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.526334867441702,1.2104865011495172,0.24036979969183359,0.7092099100339897,1.0,6/18,18.54%,TNFAIP8;RPS6KA1;RPS6KA3;NOL3;VIL1;XIAP
prerank,microtubule binding (GO:0008017),0.3759883459940388,1.2073423851616432,0.1506849315068493,0.7136208340456607,1.0,52/222,15.82%,CCDC88C;TRPV4;IRAG2;MTUS1;RAB11A;ARHGEF2;EML1;MACF1;SAXO1;MAP4;DNM3;CLIP2;DST;KIF26A;VASH2;MAP4K4;FAM161A;EML6;CAMSAP2;TTBK2;CLIP1;KIF2A;CLASP1;MAST1;LRRK2;WHAMM;MAPRE3;HOOK1;REEP2;STARD9;APC;GAPDH;CCDC181;UXT;CLASP2;GAS2L3;PRNP;NEFH;CCDC88A;NUMA1;POLB;REEP1;KIF26B;REEP3;PRC1;NAV3;MAP1LC3A;VAPA;SYBU;KIF16B;MAP2;KIF1A
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4920322990261815,-1.2050389215260677,0.2423469387755102,0.6829148272942211,1.0,6/12,18.66%,SHC1;IRS1;PIK3R1;SH2B1;GAB2;SH2B2
prerank,CoA-ligase activity (GO:0016405),0.5345542405109217,1.2047226752070481,0.26058631921824105,0.7167393808553734,1.0,5/14,14.16%,ACSM3;ACSBG1;ACSS2;SLC27A2;AACS
prerank,calcium:sodium antiporter activity (GO:0005432),-0.512165148275316,-1.20360563672102,0.24465558194774348,0.6775898787995053,1.0,2/10,3.11%,SLC24A3;SLC8A3
prerank,cGMP binding (GO:0030553),0.5734927653309752,1.2013862827836619,0.24664429530201343,0.722052365118509,1.0,1/11,0.62%,RAPGEF2
prerank,cation channel activity (GO:0005261),-0.3048755781627016,-1.2012236311643028,0.0945945945945946,0.6742149725361447,1.0,16/94,11.67%,SLC24A3;TRPM3;NALCN;PIEZO2;KCNK5;ANXA2;TRPC3;ANO1;TRPM6;ABCC9;KCNQ4;TRPC6;CALHM5;TRPV2;PKD1;CACNB2
prerank,tRNA methyltransferase activity (GO:0008175),0.531185313907249,1.19980887544103,0.2745398773006135,0.7219125683841087,1.0,5/16,11.47%,TRDMT1;TRMT5;METTL2B;METTL2A;ALKBH8
prerank,potassium ion leak channel activity (GO:0022841),-0.4669981308895469,-1.1992665437995134,0.2413793103448276,0.670529395778901,1.0,2/15,2.84%,KCNK2;KCNK5
prerank,gamma-tubulin binding (GO:0043015),-0.42070950214793423,-1.1981658190333306,0.2534435261707989,0.6643221989834194,1.0,9/21,20.92%,BRSK1;DIXDC1;TUBGCP4;OFD1;DDX3X;NDRG1;TUBGCP5;BLOC1S2;RACGAP1
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2831829531421837,-1.197477987967768,0.06060606060606061,0.6571603258226277,1.0,23/134,8.68%,SLC6A13;SLC1A3;SLC16A12;SLC7A2;SLC13A3;PDPN;SLC26A7;SLC1A5;SLCO2B1;SLCO3A1;SLC26A2;SLC25A13;GJA1;SFXN2;SLC39A8;SLC22A6;SLC6A1;SLC52A1;SLC19A1;SLC6A9;SLC27A1;SLCO2A1;MPC2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4246929253574134,1.196722247976982,0.2330345710627401,0.7262197843181214,1.0,11/60,7.30%,TEK;FLT1;TIE1;FLT4;MERTK;ACVRL1;INSR;ACVR1;FGFR3;ALK;LMTK2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4783688704951634,1.1932212397419626,0.26169590643274854,0.7316144400380475,1.0,14/30,27.41%,TNFAIP8;PTTG1;RPS6KA1;SPOCK1;RPS6KA3;NOL3;VIL1;CST3;XIAP;UBE2O;CARD16;SNCA;PRDX5;SERPINB9
prerank,guanyl ribonucleotide binding (GO:0032561),0.37272576184260897,1.1922317397478541,0.16560509554140126,0.7296097947857827,1.0,45/196,17.15%,RAPGEF2;RND1;GBP5;INSR;ATL2;RHOB;GBP4;MTG2;GCH1;NRAS;KRAS;SCG5;RRAS;RAB39A;TUBB;ATL1;GBP3;GLUD1;TUBB4B;LRRK2;MFHAS1;RAB35;MMAA;TUBA8;ARF3;EIF2B2;RRAS2;RHEBL1;RRAGD;RAC1;GBP2;RHOT2;TUBA1A;RND2;RRAD;RHOH;RAN;RHEB;ARL8A;ARL5B;GBP7;RAB27B;ARFIP2;RIT2;ARL4C
prerank,galactosyltransferase activity (GO:0008378),0.5666659490867049,1.192002407566103,0.27938671209540034,0.725567481709242,1.0,4/11,14.86%,B4GALT4;A4GALT;B4GALT6;A3GALT2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.3864630648696161,-1.1899047411792616,0.21148036253776434,0.669150947965114,1.0,10/27,21.81%,SLC41A1;SLC8A3;SLC9A2;SLC9B2;SLC9A9;SLC8A2;SLC9A6;SLC9A1;KCNK1;SLC4A8
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.5375125289861526,1.1872579916031702,0.2916666666666667,0.7343649226329515,1.0,7/13,25.71%,GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRA3;GLRB
prerank,nuclear receptor coactivator activity (GO:0030374),-0.33929560992307833,-1.1858305228320836,0.16591928251121077,0.6718196942435793,1.0,16/52,14.18%,PPARGC1B;PRKCB;ZMIZ1;TACC1;CCAR1;FGF2;MED13;RNF4;RBM14;MED14;CCDC62;ZMIZ2;CALCOCO1;USP22;ATXN7L3;ELK1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.523633827377627,1.185829611940744,0.2642089093701997,0.7335699739001063,1.0,8/17,16.89%,GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A
prerank,histone acetyltransferase binding (GO:0035035),0.4841290728624474,1.1808967760723459,0.26706231454005935,0.7429868433751671,1.0,5/21,14.63%,EPAS1;STAT1;EGR1;HIF1A;KANSL1
prerank,tubulin binding (GO:0015631),0.3594010169018877,1.177231656144262,0.1544041450777202,0.7491547140662734,1.0,65/295,15.82%,CCDC88C;TRPV4;STMN2;FYN;RABGAP1;IRAG2;MTUS1;RAB11A;ARHGEF2;EML1;SAXO1;MAP4;DNM3;TTLL7;CLIP2;DST;KIF26A;VASH2;MAP4K4;FAM161A;EML6;PRUNE1;PHF6;GABARAPL1;CLIP1;KIF2A;CLASP1;MAST1;LRRK2;WHAMM;VBP1;MAPRE3;HOOK1;TTLL1;REEP2;STARD9;APC;GAPDH;CCDC181;UXT;CLASP2;GAS2L3;PRNP;NEFH;CCDC88A;NUMA1;POLB;REEP1;BRCA1;DIP2B;KIF26B;TTLL5;REEP3;TTLL11;PRC1;NAV3;RAD51D;EFHC2;MAP1LC3A;VAPA;SYBU;KIF16B;ARL8A;MAP2;KIF1A
prerank,SUMO transferase activity (GO:0019789),-0.4541427052570442,-1.176505270060893,0.26358695652173914,0.6892099243330285,1.0,8/16,28.03%,PIAS3;HDAC4;CBX4;MDM2;TOPORS;PIAS4;UBE2I;NSMCE2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4453714886502841,1.1751783411509402,0.2778505897771953,0.7507856024907966,1.0,4/42,4.82%,CCNY;CCND2;CCND3;CCNE1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4939891239278091,1.1729303785040575,0.2857142857142857,0.7529517638734134,1.0,2/22,3.83%,ATP2A3;ATP2C1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4982492852559436,-1.1700459666161058,0.26463104325699743,0.6981994801682551,1.0,1/10,0.46%,DPYSL3
prerank,GTPase regulator activity (GO:0030695),0.366226487713946,1.1695559506795206,0.18191603875134554,0.7583978007750087,1.0,49/212,14.13%,PREX2;RAPGEF2;ARHGAP31;RGS3;PLCB1;RABGAP1;SIPA1L2;CHN2;GNAQ;ABR;ASAP2;IQGAP1;SIPA1L3;RALGAPA1;ARAP3;BCR;TBC1D30;SGSM1;ARHGAP8;RAP1GDS1;TBC1D8;SH3BP4;LRRK2;RAB3GAP2;RGS7;RANGAP1;ARHGAP25;ARRB1;TBC1D12;TBC1D5;TBC1D1;JUN;RAP1GAP2;CCDC88A;RANBP1;RANBP2;RALGAPB;OCRL;ARHGAP27;DOCK1;ITGB1BP1;USP6NL;TBC1D10A;RGS12;TBC1D4;RALGAPA2;SOS1;RHOH;TBC1D9
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3564352723226261,1.1673015614640256,0.19166666666666668,0.7605741831623521,1.0,54/269,14.45%,FZD6;SMAD6;ASB4;SMAD7;FOXO1;CASP8;HERC2;FBXO7;SUMO3;SUMO2;TUBB;SMAD2;GPI;NLK;TRAF1;TNFRSF1B;ARIH1;CUL3;GABARAPL1;ARRDC1;UBE2D1;STAT1;MFHAS1;MC4R;ARRB1;HSPA1B;PRR5L;UBA52;RPS27A;APC;ACTG1;NKD2;JUN;RTN4;FBXW7;RBX1;CUL2;BAG6;NFKBIA;LAPTM5;CCT2;DTX3L;CLU;BRCA1;TMBIM6;SNCAIP;UBE2T;YOD1;UQCRC1;UBE2J2;HIF1A;CXCR4;RAD18;MAP1LC3A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.44419814551162035,-1.1667531883398294,0.25133689839572193,0.6898874004110404,1.0,6/16,15.91%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP5F1B;ATP6V1A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.44419814551162035,-1.1667531883398294,0.25133689839572193,0.6898874004110404,1.0,6/16,15.91%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP5F1B;ATP6V1A
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.4897273438355006,1.1655426014522003,0.27988338192419826,0.7611234811384524,1.0,6/23,15.28%,HIP1;HIP1R;PLEKHA5;PHLDA3;CLVS1;KIF16B
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.35645062451503046,-1.1643909036870077,0.20735785953177258,0.6879610354783628,1.0,8/35,7.56%,MPPED2;PLCE1;PLCL1;ENPP1;ENPP3;NAPEPLD;PLCB3;GPLD1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.37719476184907613,-1.1607279861096265,0.25382262996941896,0.6891404606273854,1.0,5/26,11.19%,B3GALT1;B3GNT2;GBGT1;EXTL2;CHPF2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.34812518477133564,1.1605548107019128,0.11511511511511512,0.77049824506333,1.0,81/597,13.72%,PRDM16;SOX17;SOX13;ERG;GATA6;IRF6;GATA2;SMAD6;MSX1;KLF2;SMARCA2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ELK3;NR1I3;HEY1;KLF12;TAL1;OLIG2;IRF2;ZNF296;HNF4A;HNF1A;KLF3;KLF6;SOX18;HHEX;FLI1;HEY2;HMBOX1;KLF4;MAFK;IRF9;LEF1;ZBTB48;MAFF;RXRG;MEF2C;GATA3;BCL6B;ORC3;SNAI2;CEBPA;NFE2L2;NR1D1;TCF7L1;KLF11;FOXP1;ARID5A;JUN;EGR1;HMGB1;DHX9;ZBTB14;POLA1;ARID5B;PHOX2A;E2F7;BRCA1;HINFP;NR4A1;SOX10;KLF13;SOX6;ORC5;TLX3;SUV39H2;ELF2;IRF5;ZNF32;TGIF1;POU3F2;UNCX;TBX20;HMGB2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.38847327374282714,1.1592759312941856,0.2586605080831409,0.7694291645595617,1.0,10/91,4.06%,KCNQ1;HIP1;PLCB1;HIP1R;STXBP6;TTPA;FLII;TIRAP;SYT7;FCHO2
prerank,anion channel activity (GO:0005253),0.4085699076318986,1.1591311226344236,0.2670967741935484,0.7652467699778756,1.0,17/61,21.18%,LRRC8C;CLIC4;ANO6;GABRQ;BEST1;TTYH3;CLCN3;GABRA4;GABRA2;GABRE;VDAC1;GLRA2;GABRG3;GABRB1;VDAC3;CLCN7;GABRB3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.5573615410659258,1.1575793719726961,0.32013769363166955,0.7652054307686151,1.0,5/11,16.63%,CASP8;CASP2;CASP1;CASP7;PYCARD
prerank,actinin binding (GO:0042805),0.4728583066844928,1.154769639859713,0.2784615384615385,0.7689267516650454,1.0,4/21,4.72%,MAGI1;PROM1;PDLIM5;CSRP2
prerank,ubiquitin protein ligase binding (GO:0031625),0.3535327380158412,1.1539504601443622,0.2125,0.767091449791951,1.0,51/254,14.45%,FZD6;SMAD6;ASB4;SMAD7;FOXO1;CASP8;HERC2;FBXO7;SUMO2;TUBB;SMAD2;GPI;NLK;TRAF1;TNFRSF1B;ARIH1;CUL3;GABARAPL1;ARRDC1;UBE2D1;MFHAS1;MC4R;ARRB1;HSPA1B;PRR5L;UBA52;RPS27A;APC;ACTG1;NKD2;JUN;RTN4;FBXW7;RBX1;CUL2;BAG6;NFKBIA;LAPTM5;CCT2;CLU;BRCA1;TMBIM6;SNCAIP;UBE2T;YOD1;UQCRC1;UBE2J2;HIF1A;CXCR4;RAD18;MAP1LC3A
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.36978440234518895,-1.1527036200223029,0.2422145328719723,0.7026877285634429,1.0,8/29,16.13%,PRKAG2;KAT2B;SPRED1;SPRED2;PRKAR2A;PRKAR2B;PRKAR1A;CDKN1A
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3661985566253807,-1.1500190017015783,0.23529411764705882,0.7022976056053429,1.0,15/32,23.47%,KDM7A;EGLN3;FTO;TET2;P4HTM;TET1;KDM4A;RIOX2;JMJD4;TMLHE;KDM8;PHF8;PHYHD1;BBOX1;PHYH
prerank,calcium channel regulator activity (GO:0005246),0.44152520248137145,1.1478923693982432,0.2982456140350877,0.7802298828097264,1.0,6/37,9.26%,PRKG1;FKBP1A;MCUB;STIM2;SLC30A1;SGK1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5209528619476163,1.1478338545410252,0.31810490693739424,0.7758801858079489,1.0,5/14,11.25%,RECK;SPOCK2;TIMP3;SPOCK3;SPOCK1
prerank,RNA methyltransferase activity (GO:0008173),0.49230850739242604,1.1464794139841847,0.2959028831562974,0.7752503390470611,1.0,7/19,22.19%,TRDMT1;MRM2;TRMT5;FBLL1;FTSJ3;METTL4;FBL
prerank,C-C chemokine receptor activity (GO:0016493),0.4832902622572429,1.145528784045847,0.29393939393939394,0.7737281844016507,1.0,3/21,14.18%,CCR1;CX3CR1;CXCR4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5555909107497277,1.143287361455275,0.32482993197278914,0.7755566204590985,1.0,4/10,9.33%,IZUMO1;CD47;CD200;DSP
prerank,ligand-gated channel activity (GO:0022834),0.46039418103743723,1.1422161912425393,0.3198887343532684,0.7742323068726814,1.0,11/29,20.17%,GRID1;GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A;GABRB1;GRID2
prerank,ligand-gated anion channel activity (GO:0099095),0.49915398958796403,1.1421669998852508,0.2841091492776886,0.7700064119630442,1.0,9/17,25.71%,GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRB1;GABRB3;GABRA3;GLRB
prerank,potassium channel activity (GO:0005267),0.37962785224277645,1.141643106365425,0.26595744680851063,0.7672152696383672,1.0,17/89,18.18%,KCNN4;KCNQ1;KCNH8;KCNG3;KCNK12;KCNC1;KCNH7;GRIK5;GRIK2;KCNK9;KCNC4;KCNA1;GRIK1;KCNC2;KCNH1;KCNH5;KCNQ3
prerank,ankyrin binding (GO:0030506),0.48504742170415993,1.1402213657343738,0.3132716049382716,0.7668450338204101,1.0,4/19,7.87%,RHCG;SLC8A1;PLEC;NRCAM
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5352129161625886,1.1397113308092828,0.32059800664451826,0.7638486199372226,1.0,2/12,8.59%,RRH;ELOVL4
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5539464371359226,1.1384818825692673,0.31871838111298484,0.7630982376461903,1.0,4/10,17.86%,GABRA4;GABRA2;GABRE;GABRG3
prerank,ligand-gated ion channel activity (GO:0015276),0.4567580754810926,1.1383987814046663,0.31994459833795014,0.7591831564074099,1.0,11/30,20.17%,GRID1;GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A;GABRB1;GRID2
prerank,metal ion binding (GO:0046872),0.3428136783976906,1.135815163909113,0.16347124117053483,0.7623180091624285,1.0,70/477,12.23%,CDH13;LTBP4;NOTCH4;SYT15;RAPGEF2;ITPR3;PITPNM3;MCTP1;DYSF;PLSCR4;EML1;ESYT2;CLGN;RASGRP2;CALML4;SNRK;AOAH;CDC42BPA;CEMIP2;OXSR1;AGRN;IQGAP1;MAP3K6;ANXA3;NUCB2;SYT7;SLC8A1;CDC42BPG;SPOCK2;PIR;STK38;STK38L;NLK;STIM2;MEX3B;TPD52;ASAH2;APEX1;EFCAB9;ENDOV;EXD2;THTPA;MAST1;LRRK2;PPP3CA;SIK2;HSP90B1;MTPAP;MT2A;PLSCR1;CASQ1;CRACR2A;CDH3;CDH15;FEN1;DSPP;CDH12;HSPE1;DHH;PRNP;CDH2;SPOCK1;TRPM2;XXYLT1;PCP4;GSS;TESMIN;CALM3;MARK2;TPM4
prerank,R-SMAD binding (GO:0070412),0.5007742953936786,1.1336478353000008,0.3094512195121951,0.7639657983682978,1.0,9/18,19.55%,SMAD6;SMAD2;JUN;PMEPA1;SMURF1;DROSHA;MEN1;SMAD4;TRIM33
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5564791131236992,1.1291615100280339,0.36379613356766255,0.7724746165592885,1.0,4/10,14.66%,CASP8;CASP2;CASP1;CASP7
prerank,glycine binding (GO:0016594),0.5234093286769242,1.1249437735066352,0.34505862646566166,0.7801079245228099,1.0,5/11,25.71%,GRIN2B;GRIN3A;GLRA2;GNMT;GLRB
prerank,sodium:proton antiporter activity (GO:0015385),-0.4790458339635474,-1.1225238920445313,0.3144963144963145,0.771430535206141,1.0,5/11,19.60%,SLC9A2;SLC9B2;SLC9A9;SLC9A6;SLC9A1
prerank,mannose binding (GO:0005537),-0.46609018906915434,-1.1213623287706178,0.3153846153846154,0.7657661595106324,1.0,8/12,47.36%,LMAN1;CLN5;LMAN2;ACR;COLEC11;LMAN1L;CLEC4D;LMAN2L
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.44460025440621753,1.1204755094136074,0.3186490455212922,0.7884134236154009,1.0,13/27,26.82%,POLR2G;POLR3B;POLR1F;POLR2D;POLR1D;POLR2I;MED21;POLR2C;POLR2B;POLR2J;PRIMPOL;POLR1C;POLR1B
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.44393403020667727,1.118816470204939,0.3295774647887324,0.7885169854750926,1.0,2/29,5.46%,ACER2;HYAL2
prerank,endodeoxyribonuclease activity (GO:0004520),0.47012783767289706,1.117486607241525,0.32367149758454106,0.7880330560870373,1.0,6/20,14.51%,RBBP8;APEX1;ENDOV;FEN1;ERCC4;EXOG
prerank,sequence-specific DNA binding (GO:0043565),0.3341680613706156,1.112455795965061,0.18336673346693386,0.7978132967691829,1.0,58/590,9.72%,PRDM16;EPAS1;SOX13;ERG;GATA6;IRF6;GATA2;MSX1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;HEY1;KLF12;OLIG2;IRF2;ZNF296;HNF4A;KLF3;KLF6;SOX18;HHEX;FLI1;HEY2;HMBOX1;KLF4;MAFK;IRF9;LEF1;SP4;MAFF;RXRG;MEF2C;FOXF2;GATA3;BCL6B;CHCHD2;SNAI2;NFE2L2;NR1D1;KMT2B;MBD1;TCF7L1;ERF;KLF11;FOXP1;ARID5A;JUN;EGR1;STN1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.4781228218880428,-1.112343007780965,0.3648293963254593,0.7847294936578362,1.0,4/10,8.63%,SLCO2B1;SLCO3A1;SLC22A6;SLCO2A1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3956370498072372,1.109751548335701,0.2991128010139417,0.8012101197075596,1.0,15/56,17.16%,PITPNM3;PTPN14;CBL;ANGPT1;HYAL2;DUSP3;STAP1;PTPN1;TOB1;GRB14;RACK1;NCK1;ELMO2;SOCS5;PTPN2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.38623158207125335,-1.1090005279363453,0.31232876712328766,0.785923420086332,1.0,5/20,9.57%,LPGAT1;MOGAT3;AGPAT4;LPCAT2;DGAT1
prerank,hexose transmembrane transporter activity (GO:0015149),0.5180711712825471,1.1085679237758104,0.35823429541595925,0.8003334541576484,1.0,1/12,1.25%,SLC2A1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.33463823286903355,1.1085621571240813,0.22132796780684105,0.7962168719632414,1.0,95/431,17.15%,MAP4K2;RPS6KA5;RND1;ACVRL1;GBP5;MAP4K3;INSR;ATP1A3;ATP1A1;SNRK;ATL2;RHOB;CDC42BPA;OXSR1;SYN3;MAP3K6;GBP4;MTG2;GCH1;CDC42BPG;NRAS;KRAS;ACVR1;ATP7A;SCG5;RRAS;MAP4K4;RAB39A;STK38;TUBB;STK38L;NLK;ATL1;GBP3;MYH9;GLUD1;PGK1;PXK;TUBB4B;P2RX7;AKT3;UHMK1;MAST1;LRRK2;MFHAS1;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;TLK1;NVL;OAS2;ABCF2;RAB35;CAD;MMAA;MLKL;TUBA8;ARF3;EIF2B2;DHX9;TAP1;RRAS2;RHEBL1;RRAGD;RAC1;MINK1;ABCC6;GBP2;NEK11;GSS;MARK2;VPS4A;BTK;RHOT2;TUBA1A;RND2;RRAD;RHOH;MAP3K20;RAN;RHEB;PANK3;RRM1;ARL8A;ARL5B;GBP7;RAB27B;PFKM;ARFIP2;P2RY1;RIT2;SRPK1;ARL4C
prerank,exoribonuclease activity (GO:0004532),0.5207967815263602,1.1082194597482546,0.3608768971332209,0.793170034242148,1.0,6/12,21.98%,ZC3H12A;EXOSC3;EXOSC8;EXOSC9;EXOSC10;EXOSC1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4406664212863938,-1.105111374418699,0.32075471698113206,0.7891920079564835,1.0,5/12,7.69%,IGF1;SHC1;IRS1;PIK3R1;IGF2
prerank,protein homodimerization activity (GO:0042803),0.3312998850559308,1.1037912116112005,0.20402010050251257,0.8012971449198211,1.0,86/589,12.33%,PECAM1;FBLN5;HIP1;CEACAM1;RASIP1;STK10;PDGFB;TRIM14;FLT4;SYNE1;HIP1R;F11R;NOD1;TBX1;GBP5;B2M;IZUMO1;RBPMS;DAB2IP;CAV2;TGFB2;LRRFIP1;ADRB2;HNF4A;CADM1;SPPL2A;GBP4;HHEX;ACTN4;EXT1;GCH1;BLOC1S6;ACVR1;DEFA6;SLK;CAMK2D;SSBP1;TRIM6;KARS1;IRAK2;GBP3;MYH9;TPD52;WARS1;TOX3;EXD2;STAT1;LRRK2;ZBTB16;ELAVL1;TMEM192;HSPB1;TENM3;MTPAP;HOOK1;ACOX1;CEBPA;PTPRO;BCL2L1;ZHX3;FLRT3;TPD52L1;TCF3;MIGA1;MMAA;NECTIN1;ADAM10;MAP3K11;TAP1;TYR;ABCG4;TYROBP;CLCN1;TENM4;CCDC88A;NPM1;HIF1AN;GBP2;GSS;TRIM8;ACHE;RBM11;INPP5F;TPM4;FBXO4;SOX6
prerank,triglyceride lipase activity (GO:0004806),0.4606058152730238,1.102612171372501,0.3343465045592705,0.800368484942193,1.0,2/20,5.31%,PNLIP;LCAT
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.47013253102936314,1.102245798471333,0.359253499222395,0.7973815161175173,1.0,4/21,12.78%,KCNQ1;AKAP5;WASF2;AKAP1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5284889007767574,1.1022234592707094,0.38016528925619836,0.7934328968864469,1.0,3/12,9.16%,TRAF1;STAT1;BABAM2
prerank,1-phosphatidylinositol binding (GO:0005545),0.48768190203067535,1.1001291173818781,0.375,0.7954743009608645,1.0,5/15,17.92%,EPB41;SNX10;ZFYVE9;ZFYVE16;SCARB1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.35946057149497357,-1.0963615103732034,0.2966666666666667,0.806485751874277,1.0,9/26,10.53%,SLC6A13;SLC16A12;SLC6A12;SLC16A6;SLC16A9;SLC6A1;SLC27A1;MPC2;SLC16A11
prerank,glutamate receptor activity (GO:0008066),0.4673786106301868,1.0955332377333236,0.3511450381679389,0.8047817933820403,1.0,9/19,23.09%,GRID1;GRIA1;GRIK5;GRIK2;GRM5;GRIK1;GRM7;GRID2;GRIA2
prerank,alpha-tubulin binding (GO:0043014),0.42733969508007486,1.094032615766092,0.3555878084179971,0.8048649366888823,1.0,3/31,3.60%,TRPV4;FYN;TTLL7
prerank,endopeptidase activator activity (GO:0061133),0.5306046657608613,1.0932374233622402,0.37433155080213903,0.8032724089879765,1.0,3/10,11.27%,APH1A;VSIR;PSMD14
prerank,mannosyltransferase activity (GO:0000030),-0.3726178119827812,-1.0932135206546314,0.3355263157894737,0.8071445508378118,1.0,7/21,19.87%,TMTC4;TMTC1;PIGB;POMT1;ALG8;ALG9;PIGZ
prerank,adenylyltransferase activity (GO:0070566),0.45559242556749946,1.0923468555800693,0.34146341463414637,0.8016524695602045,1.0,6/21,8.20%,GPHN;KARS1;SELENOO;MTPAP;TENT4A;OAS2
prerank,tau protein binding (GO:0048156),0.40090104356863204,1.0859461529482344,0.359781121751026,0.8150171518352457,1.0,18/40,21.35%,FYN;SMAD2;TTBK2;PRKAA1;ROCK1;TAOK2;MARK3;ACTB;CLU;MARK2;TTBK1;PIN1;PPP2CB;MAP2;GSK3A;DYRK1A;GSK3B;MARK4
prerank,rRNA binding (GO:0019843),0.40067003020386954,1.0840048587741293,0.3446866485013624,0.816310209385489,1.0,21/42,28.95%,TST;MRPL18;NGRN;DDX28;RPS14;RPS9;CAVIN1;RPS5;DDX21;FASTKD5;ANG;MRPL11;MRPS27;NOP53;RPF2;ERI1;MRPS18C;RPL11;RPS13;MRPS18A;ERAL1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.32259239328012634,1.0833813144380928,0.231,0.8141078481810576,1.0,81/831,9.47%,PRDM16;MECOM;EPAS1;SOX17;SOX13;KLF8;ERG;GATA6;IRF6;GATA2;TAL2;MSX1;DACH1;EBF1;KLF2;CASZ1;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ZFP69;FOXO1;ELK3;NR1I3;HEY1;KLF12;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF4A;HNF1A;KLF3;KLF6;SOX18;HHEX;ACTN4;TEAD4;HEY2;KLF4;SIM2;MAFK;IRF9;LEF1;ZBTB46;ZBTB48;SP4;MAFF;SMAD2;RXRG;MEF2C;FOXF2;FOSL2;GATA3;BCL6B;STAT1;GTF2IRD1;ZBTB16;PURA;EBF3;SNAI2;RBL1;CEBPA;NFE2L2;NLRC5;NR1D1;ZBTB40;TCF7L1;TCF3;KLF11;FOXP1;ZNF182;JUN;EGR1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.47799064424516313,1.0813293315631307,0.38145896656534956,0.8157638310868988,1.0,3/18,4.50%,STXBP6;CDC42EP1;PDLIM5
prerank,MHC protein binding (GO:0042287),0.45496310366493975,1.0811357699736694,0.37577639751552794,0.8123513502318682,1.0,5/20,13.31%,TUBB;TUBB4B;ATP5F1A;TAP1;TAPBP
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.37939722590159125,-1.0802599684858671,0.3659942363112392,0.8371671882704408,1.0,4/20,5.78%,SLC39A14;SLC30A10;SLC39A8;SLC39A13
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.4384348327386284,-1.080019638687726,0.38242894056847543,0.8290592569772433,1.0,3/12,2.89%,PDE7B;PDE3A;PDE8B
prerank,GTPase binding (GO:0051020),0.3393458711131845,1.0795980468554134,0.33760683760683763,0.8125392922547571,1.0,47/194,17.82%,FGD5;UNC13B;RASIP1;RABGAP1;ARHGEF2;CAV1;IQGAP1;RAPGEF4;TBC1D30;EHD1;SGSM1;RAB34;RAPGEF6;PKN1;FGD6;FNBP1L;SIKE1;SH3BP4;LRRK2;WHAMM;RAB3GAP2;RANGAP1;MYO1C;NCKAP1;RRAGD;CYFIP1;STRN3;RANBP9;RANBP1;RANBP2;EXOC8;OCRL;GNB2;USP6NL;RAB11FIP4;RHOH;BNIP3;LCP1;YBX1;PAK2;AP3M1;PEX5L;ARFIP2;ATG14;SPTBN1;EXOC4;RUSC2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.41601013589056063,1.078519802856824,0.3645533141210375,0.8114616080489149,1.0,2/32,6.02%,SLC6A6;SFXN1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.412226568201529,-1.078087191017938,0.3350383631713555,0.8262870241699146,1.0,9/14,27.93%,ALDH4A1;MTHFD1;BLVRB;MTHFR;PYCR2;ALDH1L1;DHFR;PYCR3;ALDH1L2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3208517683129572,1.0761024588306654,0.273,0.8140018086608564,1.0,73/731,9.47%,PRDM16;MECOM;SOX17;SOX13;KLF8;ERG;GATA6;IRF6;GATA2;TAL2;DACH1;EBF1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;HEY1;KLF12;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF4A;HNF1A;KLF3;KLF6;SOX18;HHEX;TEAD4;HEY2;KLF4;MAFK;IRF9;LEF1;ZBTB48;SP4;MAFF;SMAD2;RXRG;MEF2C;FOXF2;FOSL2;GATA3;BCL6B;TRIM24;STAT1;GTF2IRD1;ZBTB16;EBF3;SNAI2;CEBPA;NFE2L2;NLRC5;NR1D1;ZBTB40;TCF7L1;TCF3;KLF11;FOXP1;ZNF182;JUN;EGR1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.45219831938589794,-1.072737539469111,0.36666666666666664,0.8334157456242981,1.0,5/12,19.60%,SLC9A2;SLC9B2;SLC9A9;SLC9A6;SLC9A1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.31991699689450415,1.0723495264076779,0.279,0.8205351735737021,1.0,72/732,9.47%,PRDM16;MECOM;SOX17;SOX13;KLF8;ERG;GATA6;IRF6;GATA2;TAL2;DACH1;EBF1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;HEY1;KLF12;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF4A;HNF1A;KLF3;KLF6;SOX18;HHEX;TEAD4;HEY2;KLF4;MAFK;IRF9;LEF1;ZBTB48;SP4;MAFF;SMAD2;RXRG;MEF2C;FOXF2;FOSL2;GATA3;BCL6B;STAT1;GTF2IRD1;ZBTB16;EBF3;SNAI2;CEBPA;NFE2L2;NLRC5;NR1D1;ZBTB40;TCF7L1;TCF3;KLF11;FOXP1;ZNF182;JUN;EGR1
prerank,symporter activity (GO:0015293),-0.46616871704745166,-1.0713605200481164,0.38235294117647056,0.8293225629550819,1.0,10/10,53.42%,SLC5A5;MFSD2A;SLC4A4;SLC46A2;SLC5A6;SLC28A2;SLC5A8;SLC28A3;SLC28A1;SLC5A12
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.35724042524742716,-1.0710885039034164,0.35714285714285715,0.8216107349752302,1.0,4/26,4.35%,PTN;PPP1R1A;SET;BOD1L1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.39526559159166136,1.069943399181981,0.3652530779753762,0.8231321579467622,1.0,6/46,4.47%,GCNT1;MFNG;POMGNT1;EXT1;MGAT5;GCNT2
prerank,phosphatase binding (GO:0019902),0.35470163374973157,1.069670010967002,0.38006952491309387,0.8199853534377526,1.0,12/105,7.36%,KCNN4;CEACAM1;FLT4;ITGA1;FBXL2;IQGAP1;SH3YL1;SMAD2;CHCHD3;MAPK1;SHOC2;HSP90B1
prerank,microtubule minus-end binding (GO:0051011),0.4929115625297665,1.068569771052129,0.3964401294498382,0.819205579559352,1.0,3/13,10.99%,MACF1;CAMSAP2;NUMA1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.32041328523760815,-1.0674574403944808,0.34172661870503596,0.8239202612727691,1.0,9/38,12.92%,SERPING1;TFPI;ANXA2;SERPINE2;SERPINH1;SERPIND1;SERPINE1;SERPINA2;SERPINF1
prerank,hydro-lyase activity (GO:0016836),-0.3134029842449888,-1.067153082797473,0.3076923076923077,0.8166354682379428,1.0,16/41,29.78%,GMDS;HACD1;CA2;ACO1;ENO2;ECHDC3;EHHADH;ECHDC2;ENO3;ACO2;FAHD2A;ALAD;ECHS1;CA4;HACD3;L3HYPDH
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4076586078088377,1.0645324326005916,0.3849493487698987,0.8261114614783448,1.0,11/34,21.85%,REXO2;EXD2;EXOSC3;CNOT6L;CNOT1;XRN2;ANGEL2;CNOT2;EXOSC9;EXOSC10;DIS3L2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4682472452870528,1.0618046996270032,0.4147465437788018,0.8294457761531965,1.0,6/17,15.36%,ATP10A;PLTP;ABCB4;PITPNA;ATP8B1;ABCA7
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4271043637320916,1.0610071770259808,0.3853868194842407,0.8277146694936621,1.0,6/28,11.08%,DAB2IP;TRAF1;MADD;STAT1;BABAM2;CASP8AP2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.42011793891889826,1.060915713345597,0.3845029239766082,0.8241304746466837,1.0,13/27,26.82%,POLR2G;POLR3B;POLR1F;POLR2D;POLR1D;POLR2I;TENT2;MED21;POLR2C;POLR2B;POLR2J;POLR1C;POLR1B
prerank,acetylation-dependent protein binding (GO:0140033),-0.3799697308171535,-1.059996382893275,0.37719298245614036,0.821752809609426,1.0,8/20,19.88%,PSME4;BRDT;TAF1;ZMYND8;BRD3;BRD9;BRD2;BRD7
prerank,lysine-acetylated histone binding (GO:0070577),-0.3799697308171535,-1.059996382893275,0.37719298245614036,0.821752809609426,1.0,8/20,19.88%,PSME4;BRDT;TAF1;ZMYND8;BRD3;BRD9;BRD2;BRD7
prerank,NAD binding (GO:0051287),-0.3526889306385685,-1.0588782276022317,0.37283236994219654,0.8171194094152783,1.0,6/26,14.94%,ALDH1A1;ME1;SIRT3;BDH2;HPGD;SIRT2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.379038707506929,-1.0583166723431767,0.35014836795252224,0.8108445221596357,1.0,13/20,34.78%,EHMT1;SETD7;METTL21A;EEF1AKMT1;SETD4;EEF1AKMT2;ANTKMT;KMT5A;ATPSCKMT;ETFBKMT;EEF1AKMT3;EHMT2;METTL21C
prerank,C-C chemokine binding (GO:0019957),0.4438545229600505,1.0560574350882117,0.39730134932533734,0.8333453776699523,1.0,3/22,14.18%,CCR1;CX3CR1;CXCR4
prerank,calcium-release channel activity (GO:0015278),0.45473559201595837,1.0550210395883224,0.42362204724409447,0.8324207452236323,1.0,4/17,11.34%,ITPR3;MCOLN1;TPCN2;TRPM2
prerank,RNA polymerase II complex binding (GO:0000993),-0.33991611616029105,-1.0544908126344208,0.3774193548387097,0.8137862101349843,1.0,12/32,15.98%,SCAF8;ERCC5;PAF1;CTR9;PCIF1;URI1;UVSSA;GTF2B;RTRAF;HNRNPU;PCF11;WAC
prerank,single-stranded RNA binding (GO:0003727),0.3922851743104953,1.053792520302445,0.38255977496483823,0.8318547785733508,1.0,9/43,13.22%,IFIH1;RBM7;ENDOV;POLR2G;DHX9;POLR2D;AGO4;RBM11;FXR1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3627053962157596,-1.05290800925821,0.4012539184952978,0.8105681906980565,1.0,3/24,5.77%,DAPK1;CAMK1D;CAMK1
prerank,small GTPase binding (GO:0031267),0.332304903455353,1.052708281257736,0.3905579399141631,0.8306704708458639,1.0,28/169,11.00%,FGD5;UNC13B;RABGAP1;ARHGEF2;CAV1;IQGAP1;RAPGEF4;TBC1D30;EHD1;SGSM1;RAB34;RAPGEF6;PKN1;FGD6;SIKE1;SH3BP4;LRRK2;WHAMM;RAB3GAP2;RANGAP1;MYO1C;NCKAP1;CYFIP1;STRN3;RANBP9;RANBP1;RANBP2;EXOC8
prerank,histone demethylase activity (GO:0032452),-0.3458717129923952,-1.0495585790509736,0.34812286689419797,0.8121794808475699,1.0,10/27,19.44%,KDM7A;JARID2;JMJD1C;JMJD6;FBXL19;KDM4A;RIOX2;KDM6B;KDM8;PHF8
prerank,5'-3' exonuclease activity (GO:0008409),0.46919243926633947,1.0475729526975899,0.3901639344262295,0.8408677919590869,1.0,7/14,19.83%,TRIR;FEN1;XRN2;XRN1;EXOG;DXO;CPSF3
prerank,titin binding (GO:0031432),0.4825664532862529,1.0462944535552383,0.4220472440944882,0.8405267567657543,1.0,3/13,12.09%,MYBPC3;CAMK2D;CALM3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3687043584648087,1.044970734020534,0.40561224489795916,0.840330695328575,1.0,9/60,7.30%,TEK;FLT1;TIE1;FLT4;MERTK;INSR;FGFR3;ALK;LMTK2
prerank,sterol binding (GO:0032934),-0.2948339992383734,-1.0446765053235876,0.3645320197044335,0.8192861917168184,1.0,18/56,17.01%,APOD;SIDT1;ABCA1;GRAMD1C;RORA;OSBPL8;SCP2;OSBP2;PTCH1;ERLIN1;INSIG2;CD81;GRAMD1A;OSBPL7;NR1H3;OSBPL11;SCAP;GRAMD1B
prerank,transition metal ion binding (GO:0046914),0.31530560203570934,1.0435628121939011,0.3971486761710794,0.840076402957715,1.0,59/397,11.78%,NOS1;MYRIP;NOS3;ACE;GDA;CRIP2;ARHGEF2;POMGNT1;DUSP12;MSRB3;KLF7;IFIH1;ATOX1;MGAT5;GCH1;KLF4;FBXL5;ATP7A;LANCL1;TNFSF10;RNF125;SHANK3;ARG1;ARIH1;SMPDL3A;ASAH2;IL1A;PCK2;PGGT1B;TRIM24;EXD2;CLIP1;KDM3A;KPNB1;MTPAP;MT2A;PLSCR1;GRIN2B;KMT2B;CAD;FEN1;MBD1;EGR1;DHH;PRNP;TYR;ADPRM;PTPN1;TET3;TNKS;TAB2;ISCA2;MGAT1;HIF1AN;XXYLT1;ALKBH8;SAP30L;TRIM8;GALNT4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4139641992965363,1.0428049544342113,0.40746268656716417,0.8383063731903968,1.0,3/24,7.35%,ITPKB;IP6K3;CMPK1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3198293187183318,1.0426213477677095,0.39282051282051283,0.8351763135764916,1.0,50/291,12.34%,RAPGEF2;MAP4K2;RPS6KA5;ACVRL1;MAP4K3;INSR;ATP1A3;ATP1A1;SNRK;CDC42BPA;OXSR1;SYN3;MAP3K6;CDC42BPG;ACVR1;RAPGEF4;ATP7A;MAP4K4;STK38;STK38L;NLK;MYH9;GLUD1;PGK1;PXK;P2RX7;AKT3;UHMK1;MAST1;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;TLK1;NVL;OAS2;ABCF2;CAD;MLKL;EIF2B2;DHX9;TAP1;ACSS2;MINK1;ABCC6;NEK11;GSS;MARK2;VPS4A
prerank,kinase activity (GO:0016301),0.3453391085965797,1.042102099439435,0.39105504587155965,0.832956889222383,1.0,28/109,17.77%,ITPKB;IP6K3;PRKD1;PIK3C2A;IPPK;IDNK;PGM2L1;MAP4K4;PGK1;LRRK2;STK39;RFK;DGKH;PIK3C3;NMRK1;PIK3CB;PAPSS1;PANK3;AGK;DGKI;CKMT1A;PKN2;TRRAP;GK5;DOLK;TRIB3;CERKL;PIK3C2B
prerank,miRNA binding (GO:0035198),0.41548129638401726,1.0391764366477703,0.4190340909090909,0.8372505182198504,1.0,9/30,17.40%,PUM2;ZC3H12A;ELAVL1;ZNF346;ZC3H7A;AGO4;DDX21;YBX1;TUT7
prerank,metalloexopeptidase activity (GO:0008235),-0.2960390635152526,-1.0390076801220058,0.3760330578512397,0.8278085950676173,1.0,14/51,13.76%,AEBP1;CPQ;MMP14;ANPEP;CPE;AGBL3;METAP1D;CPXM2;MMP16;ZMPSTE24;CPXM1;ENPEP;RNPEP;METAP1
prerank,death domain binding (GO:0070513),0.4905922371890504,1.0382716767785611,0.43492586490939045,0.8359338497350595,1.0,6/11,19.80%,DAP;IRGM;CRADD;BCL2L1;RACK1;MCL1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.38713553222179786,-1.0372974591939608,0.3916913946587537,0.8248768412999683,1.0,6/16,22.66%,SLC26A7;SLC26A2;SLC26A6;SLC4A8;CFTR;CLCN6
prerank,outward rectifier potassium channel activity (GO:0015271),0.48901456833447365,1.0370173315299869,0.4201388888888889,0.8355422505430732,1.0,1/11,0.28%,KCNQ1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.396529101195233,-1.0358211205334047,0.4117647058823529,0.8217129431888138,1.0,6/15,16.22%,KMT2C;ASH2L;SETD1A;SETD1B;WDR5;SETD4
prerank,DNA binding (GO:0003677),0.30967149957104717,1.034398756963131,0.38038038038038036,0.8390344161982016,1.0,100/694,13.95%,PRDM16;MECOM;EPAS1;SOX13;ERG;IRF6;TAL2;KLF2;SMARCA2;TBX1;NR4A2;FOXO4;FOXO1;KLF12;AIM2;IRF2;LRRFIP1;HNF4A;HNF1A;APP;ARID3B;HHEX;FLI1;RBBP8;HEY2;HMBOX1;ING2;SIM2;BCLAF3;MAFK;SYCP2;LEF1;SSBP1;SP4;MAFF;SMAD2;FOXF2;RPL7;APEX1;GATA3;RTF1;SETX;ENDOV;CHCHD2;CHRAC1;RYBP;STAT1;ZC3H12A;ZBTB16;PURA;SNAI2;CEBPA;NFE2L2;POLR2G;TIGD3;FEN1;MBD1;TCF7L1;TCF3;ERF;POGK;ARID5A;JUN;EGR1;HMGB1;MLF1;DHX9;HP1BP3;STN1;TIGD2;POLR2D;ZBTB14;NUP35;POLA1;BRIP1;APLP2;POLG2;PCBP1;ARID5B;SAP30L;MTERF2;BRCA1;ILF2;HINFP;NR4A1;SMARCAD1;SOX10;CBFB;SOX6;XRN1;GLYR1;IRF5;POU3F2;GTF2A1;HIF1A;CR2;HMGB2;ERCC4;RAD1;RAD51D
prerank,ATP binding (GO:0005524),0.3185071567240674,1.0329102771053829,0.42782969885773625,0.8392245388165906,1.0,46/266,12.34%,MAP4K2;RPS6KA5;ACVRL1;MAP4K3;INSR;ATP1A3;ATP1A1;SNRK;CDC42BPA;OXSR1;SYN3;MAP3K6;CDC42BPG;ACVR1;ATP7A;MAP4K4;STK38;STK38L;NLK;MYH9;PGK1;PXK;P2RX7;AKT3;UHMK1;MAST1;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;TLK1;NVL;OAS2;ABCF2;CAD;MLKL;EIF2B2;DHX9;TAP1;MINK1;ABCC6;NEK11;GSS;MARK2;VPS4A
prerank,metal ion:proton antiporter activity (GO:0051139),-0.42286029342060183,-1.0327622227177757,0.4170984455958549,0.8227313420617763,1.0,5/13,19.60%,SLC9A2;SLC9B2;SLC9A9;SLC9A6;SLC9A1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.41732991384172546,1.0325458099262628,0.43923865300146414,0.8365994902650961,1.0,2/27,1.83%,ATP2A3;ATP2B4
prerank,phosphate ion binding (GO:0042301),0.4993058469274003,1.0323120198009086,0.43270868824531517,0.8337135537590715,1.0,5/10,24.92%,CHST14;RELA;ADSS2;MTHFD2;RPH3A
prerank,cytokine activity (GO:0005125),-0.25199495372847913,-1.0313643796946266,0.37037037037037035,0.8196697216950191,1.0,14/131,9.44%,BMP6;IL34;WNT4;BMP5;BMP7;BMP4;WNT6;WNT5A;TNFRSF11B;FGF2;CXCL16;WNT9A;VEGFA;IL17D
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3976563316804413,1.0311815945380458,0.42143906020558003,0.8331189313578501,1.0,7/33,12.36%,REXO2;EXD2;EXOSC3;CNOT6L;XRN2;ANGEL2;XRN1
prerank,iron ion binding (GO:0005506),-0.2970131315942833,-1.029069314368619,0.42083333333333334,0.818379214542025,1.0,13/48,14.76%,AGMO;KDM7A;NFU1;EGLN3;FTO;JMJD6;TET2;AOX1;FDX1;TET1;ETHE1;SCD;FXN
prerank,tau-protein kinase activity (GO:0050321),0.43620192415315856,1.0284041283059175,0.43617021276595747,0.8369061367072058,1.0,12/20,21.35%,FYN;TTBK2;PRKAA1;ROCK1;TAOK2;MARK3;MARK2;TTBK1;GSK3A;DYRK1A;GSK3B;MARK4
prerank,Tat protein binding (GO:0030957),0.5019109865419099,1.027540067270242,0.46481178396072015,0.8357360610295489,1.0,5/10,23.58%,GABARAPL1;NPM1;ACTB;DNAJA1;DLL1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4588048120964491,1.025286976050839,0.43390357698289267,0.838073129536188,1.0,3/15,7.43%,PIK3R6;CISH;SOCS6
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3850887709391076,1.0199769937051602,0.43424657534246575,0.8479996118476307,1.0,14/40,22.19%,PCMTD1;COMTD1;PCMT1;METTL2B;METTL2A;SETD3;FBLL1;GAMT;METTL18;ARMT1;METTL4;GNMT;LCMT1;FBL
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3956663168747674,-1.0191333258152944,0.45706371191135736,0.8392415609828191,1.0,2/14,2.75%,SLC26A7;SLC26A2
prerank,"DNA binding, bending (GO:0008301)",0.4655581977108599,1.0185446266482487,0.4536741214057508,0.8481665852160928,1.0,5/14,13.72%,HHEX;LEF1;HMGB1;SAP30L;HMGB2
prerank,ATPase regulator activity (GO:0060590),-0.30586485832378846,-1.0178190812262786,0.4225352112676056,0.8357360559884387,1.0,16/38,23.34%,ATP1B3;TOR1AIP1;SIL1;ATP5IF1;DNAJB2;FNIP1;BAG1;ATP1B1;BAG3;TSC1;ATP1B2;GRPEL2;KATNB1;DNAJC15;DNAJB4;BAG2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.44886940364879047,1.017305524440971,0.45468277945619334,0.8476747719482555,1.0,7/16,26.47%,MTMR10;MTMR11;INPP5F;SYNJ1;MTMR14;MTMR2;MTMR9
prerank,chloride channel regulator activity (GO:0017081),0.46330630237203496,1.0167728603687496,0.4415156507413509,0.8454370462914766,1.0,4/14,9.26%,VTI1B;STX7;VAMP8;SGK1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.32316490173292256,-1.0134878827435012,0.47959183673469385,0.8401388713428128,1.0,13/33,16.96%,SCAF8;ERCC5;PAF1;CTR9;URI1;LLPH;UVSSA;GTF2B;RTRAF;HNRNPU;PCF11;WAC;AR
prerank,endopeptidase activity (GO:0004175),-0.22749642616745316,-1.0121021575065254,0.47368421052631576,0.8365954879867474,1.0,59/257,19.34%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;ADAMTSL5;BACE2;MMP14;HTRA3;ADAMTS17;RHBDL3;ADAMTS5;ADAMTS10;DPP4;USP33;USP20;BACE1;ADAMTS3;ADAM9;ADAM19;USP9X;FAP;USP13;USP11;F3;ADAMTS15;ADAMTS9;ADAM33;MMP2;USP1;CASP3;ADAMTSL4;PSMB3;MMP16;KLK2;ZMPSTE24;MMP19;UCHL1;SENP1;ADAMTS14;PSMA3;PCSK7;USP8;PSMB4;CTSC;ADAMTS16;PSMB7;MMP11;MBTPS1;USP34;CTSL;MASP1;ACE2;HTRA2;ADAMTS19;RHBDF1;KDM8;HTRA4;LGMN
prerank,mechanosensitive ion channel activity (GO:0008381),0.47272000868590647,1.0095149770234557,0.46551724137931033,0.8600291446713351,1.0,2/12,7.99%,PIEZO1;TMC7
prerank,double-stranded DNA binding (GO:0003690),0.30345661091887105,1.008229053097587,0.4593781344032096,0.8599124898985192,1.0,70/531,13.72%,ERG;GATA6;IRF6;GATA2;MSX1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ELK3;NR1I3;HEY1;KLF12;AIM2;OLIG2;IRF2;ZNF296;HNF4A;KLF3;KLF6;SOX18;FLI1;RBBP8;HEY2;HMBOX1;KLF4;IRF9;LEF1;ZBTB48;MAFF;SMAD2;RXRG;MEF2C;APEX1;GATA3;BCL6B;STAT1;PURA;SNAI2;NR1D1;FEN1;MBD1;TCF7L1;KLF11;FOXP1;JUN;EGR1;HMGB1;DHX9;ZBTB14;POLG2;PHOX2A;E2F7;NR4A1;SOX10;KLF13;TLX3;ELF2;IRF5;ZNF32;TGIF1;POU3F2;UNCX;TBX20;HMGB2
prerank,voltage-gated potassium channel activity (GO:0005249),0.34221135006854525,1.00805526387847,0.44594594594594594,0.8568919908348348,1.0,5/80,3.70%,KCNQ1;KCNE3;KCNH8;KCNN3;KCNG3
prerank,syntaxin binding (GO:0019905),0.3563570387245807,1.007363115514068,0.44545454545454544,0.8551060995932809,1.0,19/61,18.16%,UNC13B;RAB11A;CACNA1A;BLOC1S6;STX7;TMED10;LRRK2;VAMP8;TMED9;SYPL1;STXBP3;NSF;CPLX1;SNPH;STXBP5;STXBP5L;PTPN2;SYT2;SYT1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4545766168098041,1.0063231760930467,0.4618973561430793,0.8541511281708525,1.0,6/14,26.47%,MTMR10;MTMR11;SYNJ1;MTMR14;MTMR2;MTMR9
prerank,snRNA binding (GO:0017069),-0.2966374473267235,-1.0055042167697728,0.45,0.8476799408580266,1.0,15/42,25.30%,SNRNP70;PRPF8;COIL;GEMIN5;PRPF31;TUT1;SNRPA1;SNRPA;HNRNPU;SNRPD3;LSM11;TOE1;NCBP2;LSM10;LARP7
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.41589725388860144,-1.0037693713863742,0.45595854922279794,0.8452563705016646,1.0,3/12,5.43%,BACE2;BACE1;HM13
prerank,MHC class II protein complex binding (GO:0023026),-0.4199147076269868,-1.0014787651577666,0.4691075514874142,0.8445875974133211,1.0,3/11,17.87%,ATP1B1;CD81;CD74
prerank,phospholipase binding (GO:0043274),-0.39541377505466063,-1.001008230571607,0.45161290322580644,0.8389472217457679,1.0,3/13,6.87%,ARHGAP6;PRKN;SRC
prerank,cyclic nucleotide binding (GO:0030551),0.4183557803905633,0.9995993142498559,0.4566813509544787,0.86728297223508,1.0,2/21,4.25%,RAPGEF2;RAPGEF4
prerank,phospholipase activator activity (GO:0016004),-0.4259831679223496,-0.9988330392814996,0.4396135265700483,0.8379546678825909,1.0,3/10,6.87%,ARHGAP6;STX4;SRC
prerank,kinesin binding (GO:0019894),0.4049833288551928,0.9976817048960609,0.47144948755490484,0.8683589320913139,1.0,8/27,16.24%,TTBK2;SPAG9;NEFH;ACTB;KLC2;PRC1;ARHGEF10;PLEKHM2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3803700453754044,0.9969419532462878,0.45614035087719296,0.8667941945795086,1.0,7/37,10.06%,GARS1;VARS1;VARS2;KARS1;FARSB;WARS1;FARS2
prerank,nuclear export signal receptor activity (GO:0005049),0.4725140426923514,0.9956291863995469,0.48257839721254353,0.8665163311046413,1.0,4/11,14.46%,XPO6;XPO1;NUP42;RAN
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3962802047749349,-0.9935911682134433,0.44986449864498645,0.8455004655558831,1.0,4/14,10.76%,USP9X;USP13;OTUD7B;MINDY3
prerank,androgen receptor binding (GO:0050681),-0.3328066162048349,-0.9935105938577887,0.4483870967741935,0.8390683193324932,1.0,4/25,5.29%,DDX5;PRKCB;SNW1;NSD1
prerank,metalloaminopeptidase activity (GO:0070006),-0.37021404473952585,-0.9930676380966525,0.46005509641873277,0.8337744997102549,1.0,5/16,13.08%,MMP14;ANPEP;MMP16;ENPEP;RNPEP
prerank,adrenergic receptor binding (GO:0031690),0.4377451596126033,0.9920346715825534,0.4788273615635179,0.8721766744818349,1.0,2/16,5.28%,RAPGEF2;AKAP5
prerank,chloride channel inhibitor activity (GO:0019869),0.47827016961604485,0.9916321445240079,0.4661016949152542,0.8697647016302902,1.0,3/10,7.44%,VTI1B;STX7;VAMP8
prerank,frizzled binding (GO:0005109),-0.31130278512105203,-0.9915823045300984,0.4536082474226804,0.8308535975889351,1.0,7/34,10.50%,WNT4;RNF43;WNT6;WNT5A;WNT9A;FZD7;SDCBP
prerank,transcription coactivator binding (GO:0001223),-0.34443412263985085,-0.9902999218437538,0.46285714285714286,0.8279532802493352,1.0,5/20,16.96%,THRB;RORA;SMAD3;TERT;AR
prerank,acid-thiol ligase activity (GO:0016878),0.45258255534314795,0.9860944558332904,0.5033003300330033,0.8799001605973393,1.0,4/13,14.16%,ACSM3;ACSS2;SLC27A2;AACS
prerank,TBP-class protein binding (GO:0017025),0.41753001087407704,0.9844000169253707,0.49487554904831627,0.8805894381487435,1.0,9/21,17.31%,HHEX;BRF2;GTF2A1;TAF1B;PSMC1;PSMC5;TAF11;ESR1;DRAP1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2985944547055476,-0.9837313519603191,0.4708333333333333,0.8389215155922529,1.0,12/37,19.79%,SLC22A8;SLCO2B1;SLCO3A1;SLC22A6;SLC22A4;SLCO2A1;COX10;UQCRQ;COX7A2L;UQCRH;SLC16A7;SLCO5A1
prerank,ribosomal large subunit binding (GO:0043023),-0.4073659340099193,-0.9826325752124304,0.4877450980392157,0.8354930990256239,1.0,5/11,18.57%,NEMF;MRRF;CPEB2;NMD3;MALSU1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4361528875938802,0.9819342026632863,0.48042168674698793,0.8831689598707494,1.0,7/15,23.00%,PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,RNA polymerase binding (GO:0070063),0.42480504906267336,0.9817697170051507,0.4916286149162861,0.8801759855307376,1.0,6/18,15.59%,STOM;TCERG1L;DHX9;BRCA1;ANP32B;PKN2
prerank,phosphatidylglycerol binding (GO:1901611),0.45855779454284795,0.9800062699706423,0.4926829268292683,0.8810462501044699,1.0,3/13,8.91%,PLTP;UQCC3;PITPNA
prerank,syntaxin-1 binding (GO:0017075),0.40792138577445375,0.9787320058276854,0.48353293413173654,0.8807521587916514,1.0,9/22,18.16%,UNC13B;LRRK2;SYPL1;STXBP3;NSF;CPLX1;SNPH;STXBP5;SYT1
prerank,translation initiation factor activity (GO:0003743),0.3720217803770836,0.978667257645427,0.4979020979020979,0.8775585446306934,1.0,13/36,18.03%,EIF3B;EIF2B2;EIF1;EIF3K;EIF3I;EIF3F;EIF3G;EIF3A;EIF2A;EIF2S1;EIF3H;EIF3M;COPS5
prerank,retinoic acid receptor binding (GO:0042974),0.4239482139918992,0.9785113580190381,0.4728434504792332,0.8745916623857526,1.0,4/17,10.30%,NR4A2;ACTN4;ARID5A;CNOT1
prerank,regulatory RNA binding (GO:0061980),0.375288118799593,0.976022185886977,0.48655913978494625,0.8772748201560576,1.0,10/38,17.40%,PUM2;ZC3H12A;ELAVL1;ZNF346;ZC3H7A;DHX9;AGO4;DDX21;YBX1;TUT7
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4404109350349161,0.9759890127698758,0.49331103678929766,0.8740316167967969,1.0,9/13,31.74%,TRMT5;TRMT10B;TRMT1L;TRMT1;THUMPD2;TRMT10A;TRMT10C;FTSJ1;TRMT11
prerank,peptidase inhibitor activity (GO:0030414),-0.3036552665765293,-0.9759017749542374,0.487012987012987,0.8459403129993099,1.0,7/33,11.52%,TFPI;GPC3;TIMP2;PSMF1;RENBP;SERPIND1;ITIH2
prerank,kinase activator activity (GO:0019209),-0.32065681446634187,-0.9753478383207065,0.477124183006536,0.8409694031966541,1.0,3/30,5.58%,PRKAG2;WNK1;GPRC5C
prerank,ion channel activity (GO:0005216),0.3333823291037121,0.9728491376253178,0.5199516324062878,0.8785027741527998,1.0,13/80,11.34%,TRPV4;PIEZO1;MCUB;GRID1;GRIA1;MCOLN1;TMC7;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;TRPM2
prerank,nucleosomal DNA binding (GO:0031492),-0.3402551117932289,-0.9701945387681901,0.49258160237388726,0.8478273697974662,1.0,8/21,21.93%,CHD4;SMARCB1;HDAC1;HMGA2;MTA2;MBD3;H1-0;ACTL6A
prerank,fatty acid synthase activity (GO:0004312),0.46344561524947736,0.9694394974403068,0.5185185185185185,0.8832561609846455,1.0,4/10,22.19%,ELOVL4;ELOVL7;ELOVL5;OXSM
prerank,protein heterodimerization activity (GO:0046982),0.30979268492476686,0.9680998406698269,0.5431693989071038,0.8832650882488859,1.0,33/178,14.54%,EPAS1;HIP1;PDGFB;NR4A2;ATP1A1;FBXO7;EXT1;RALGAPA1;MEF2C;IRAK2;TENM3;BCL2L1;ZHX3;TCF3;MIGA1;ABCG4;RRAGD;TENM4;CYBA;RALGAPB;NR4A1;TPM4;YWHAH;FXR1;GTF2A1;HIF1A;SDCBP2;ITGA3;RALGAPA2;FZD9;USF2;RAN;VAPA
prerank,water transmembrane transporter activity (GO:0005372),0.4689002783457651,0.9680139891162086,0.5282051282051282,0.8801737697318252,1.0,1/11,2.28%,AQP11
prerank,myosin II binding (GO:0045159),0.4565542242051732,0.966413441495941,0.5158450704225352,0.8808361474538675,1.0,4/10,17.01%,SHROOM4;SHROOM1;STXBP5;STXBP5L
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.41001862204819384,-0.9664093115948008,0.5049261083743842,0.8513501640493121,1.0,3/10,11.67%,CACNA1C;CACNB1;CACNB2
prerank,leucine zipper domain binding (GO:0043522),-0.4130634170974926,-0.9658577322642505,0.4949748743718593,0.8462695046997336,1.0,1/10,0.42%,PAWR
prerank,peptidase activator activity (GO:0016504),0.4007835725246933,0.964445210905472,0.529320987654321,0.8822120684880367,1.0,6/22,11.27%,CAV1;MAL;APH1A;CASP8AP2;VSIR;PSMD14
prerank,cholesterol binding (GO:0015485),-0.27475231992647564,-0.9625152939734073,0.49572649572649574,0.8487211309843687,1.0,14/47,17.01%,APOD;SIDT1;ABCA1;GRAMD1C;OSBPL8;SCP2;OSBP2;PTCH1;ERLIN1;CD81;GRAMD1A;OSBPL7;NR1H3;GRAMD1B
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2886570039611255,0.9625084524411126,0.5774358974358974,0.8833571209801365,1.0,59/346,15.35%,LMO7;ASB4;TRIM14;RNF103;ZNRF1;TRIM69;CBL;HERC2;FBXO7;UBA7;FBXL14;FBXL5;TRIM11;TRIM6;RNF38;TRAF1;RNF125;RNF185;ARIH1;UBE2Q1;CUL3;UBE2D1;TRIM24;KLHL20;WWP1;UBE3A;SIAH2;RNF141;RNF115;ZNRF3;RNF128;RBX1;CUL2;TRIM25;RNF144B;TRIM47;TRIM17;FBXW2;NEDD4L;OBI1;DTX3L;BRCA1;SMURF1;KCTD10;RSPRY1;FBXO4;UBE2T;RNF103-CHMP3;RMND5B;UBE2J2;FBXO2;UBE2E1;FBXO3;UBE3B;UBE2D3;NHLRC1;TRIM2;IRF2BP1;TRAIP
prerank,pentosyltransferase activity (GO:0016763),-0.2949270586274521,-0.9623093372860577,0.4962686567164179,0.8431328252532212,1.0,13/36,24.65%,LARGE1;PARP8;LACC1;SIRT3;ART3;PNP;SIRT2;QPRT;PARP6;PARP1;PARP3;PPAT;PARP2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3785821233679217,0.9617895540530672,0.49857142857142855,0.8816304917362024,1.0,12/28,25.04%,APEX1;ENDOV;FEN1;RPP38;EDC3;ELAC2;DROSHA;POP1;RNASEH2A;NUDT16;RNASEH1;NUDT16L1
prerank,omega peptidase activity (GO:0008242),-0.24515050755038795,-0.9607503140913664,0.5961538461538461,0.8411245821214759,1.0,26/89,20.43%,USP33;USP20;ASRGL1;USP9X;USP13;USP11;USP50;USP1;USP3;OTUD6B;GGT5;OTUD7B;MINDY3;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;GGT7;USP34;VCPIP1;JOSD2;USP46;USP2
prerank,GABA receptor activity (GO:0016917),0.40539582073423913,0.9587708022092698,0.512937595129376,0.8854278066463024,1.0,7/21,21.18%,GABRQ;GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3
prerank,neuropeptide receptor binding (GO:0071855),0.4376000474019927,0.9567473521055032,0.5232,0.8869362254404993,1.0,4/14,23.51%,GAL;APLN;NMU;NTS
prerank,SUMO binding (GO:0032183),0.43669682385450503,0.9567364869257788,0.5310344827586206,0.8837623670605077,1.0,4/13,18.04%,HERC2;CASP8AP2;HABP4;USPL1
prerank,tropomyosin binding (GO:0005523),0.4200122756242106,0.9537706698690894,0.5188679245283019,0.8874865557387205,1.0,1/16,0.61%,NEBL
prerank,DNA secondary structure binding (GO:0000217),0.38093905745093753,0.9533288429400967,0.4884393063583815,0.8852115761874731,1.0,11/31,24.24%,RBBP8;MEF2C;HMGB1;HMGB2;RAD51D;RAD18;XPC;MEN1;BLM;GEN1;WRN
prerank,exonuclease activity (GO:0004527),0.3477430480322629,0.9510979184649249,0.5135869565217391,0.8870290657806085,1.0,17/46,21.98%,REXO2;APEX1;EXD2;ZC3H12A;TRIR;EXOSC3;FEN1;EXOSC8;XRN2;RAD1;EXOG;EXD1;DXO;EXOSC9;CPSF3;EXOSC10;EXOSC1
prerank,3'-5' exonuclease activity (GO:0008408),0.34845365304252957,0.94814722149311,0.5262430939226519,0.8907987413801204,1.0,11/45,17.55%,REXO2;APEX1;EXD2;TRIR;EXOSC3;CNOT6L;XRN2;ANGEL2;RAD1;EXD1;EXOSC9
prerank,gated channel activity (GO:0022836),0.4290930866028819,0.9463591280941865,0.5331125827814569,0.8917837192155256,1.0,2/14,7.99%,PIEZO1;TMC7
prerank,vinculin binding (GO:0017166),0.43209271395176296,0.9448092461641182,0.5284280936454849,0.8920540701927056,1.0,3/11,12.95%,UTRN;CTNNA1;SORBS3
prerank,cytokine receptor activity (GO:0004896),0.3189536184046619,0.9442250383951585,0.5587878787878788,0.8900837606720072,1.0,9/83,7.31%,CCR1;LIFR;IFNGR1;CSF2RB;IL17RD;IFNAR1;CMKLR1;IL1RAP;IL20RB
prerank,voltage-gated ion channel activity (GO:0005244),0.4259884933597641,0.9435783204856985,0.5270935960591133,0.888454749639852,1.0,6/14,24.48%,ANO6;VDAC1;CACNA1E;VDAC3;VDAC2;HCN1
prerank,potassium:proton antiporter activity (GO:0015386),-0.41493670790266624,-0.9435076810837565,0.5320197044334976,0.8792401513039909,1.0,4/10,19.60%,SLC9A2;SLC9A9;SLC9A6;SLC9A1
prerank,solute:proton symporter activity (GO:0015295),-0.3608453026694137,-0.9430573997730517,0.5418994413407822,0.8740815935839001,1.0,4/16,11.70%,SLC2A13;SLC17A5;SLC39A8;SLC2A10
prerank,endopeptidase inhibitor activity (GO:0004866),0.31686825519364176,0.941757423456471,0.5491400491400491,0.8893083755689748,1.0,13/82,11.25%,RECK;SERPINI1;APP;SPOCK2;TIMP3;FURIN;SPOCK3;PTTG1;GAPDH;ROCK1;PRNP;SPINT2;SPOCK1
prerank,histone deacetylase binding (GO:0042826),-0.23907087416365486,-0.9414626210909077,0.5675675675675675,0.8720474237648534,1.0,20/88,15.07%,GLI3;CHD4;PRKN;TOP2B;KAT2B;NUDT21;NIPBL;DACT1;LCOR;CAMTA2;NACC1;BHLHE41;HDAC4;ZMYND15;HDAC1;HDAC6;AKAP8L;SIRT2;BCOR;MTA2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.346162657434051,-0.9404148750456356,0.521613832853026,0.8684819436072226,1.0,2/18,0.62%,ALDH1A1;ALDH1A2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.39492000127279914,-0.9399653744970022,0.565,0.863645706774137,1.0,2/10,9.62%,DSE;RENBP
prerank,methylated histone binding (GO:0035064),-0.26222945126968117,-0.9396763303279271,0.5728155339805825,0.8582828530710152,1.0,20/62,20.07%,TDRD3;KDM7A;PYGO1;MTF2;MORC4;TAF1;ZMYND8;WDR5;NCAPG2;RRP8;BPTF;MSH6;MSL3;MPHOSPH8;KDM4A;TAF7;KDM8;PHF8;MORC3;ATRX
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.33985893656228494,-0.9384147210963925,0.5276967930029155,0.855546921924737,1.0,3/21,5.83%,FGF1;FGF2;KL
prerank,ubiquitin-dependent protein binding (GO:0140036),0.45413084517622937,0.9378525480959595,0.5343915343915344,0.8950677726436469,1.0,3/10,11.28%,ANKRD13A;DNAJC2;LAPTM5
prerank,ligand-gated cation channel activity (GO:0099094),0.3238911658662921,0.9375676954562495,0.5674362089914945,0.8925877658280434,1.0,11/75,11.34%,KCNN3;P2RX7;GRIA1;MCOLN1;GRIN2B;GRIN2C;ASIC2;GRIK5;GRIK2;GRIN3A;TRPM2
prerank,Wnt-activated receptor activity (GO:0042813),0.41477985234274495,0.9374751791838217,0.5330188679245284,0.889677516236808,1.0,5/15,14.28%,FZD6;TSPAN12;LRP5;FZD9;FZD3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.41788501048332993,0.9367451574963606,0.5347003154574133,0.8882053817803917,1.0,4/15,14.72%,HS3ST1;HS3ST6;HS3ST5;NDST4
prerank,vitamin D receptor binding (GO:0042809),-0.36730341259120386,-0.9345732304722976,0.5145118733509235,0.8589752881543123,1.0,5/14,15.76%,SNW1;MED13;MED14;MED16;TAF7
prerank,methylation-dependent protein binding (GO:0140034),-0.26451713974557356,-0.9340312840915769,0.5944700460829493,0.8544559951369233,1.0,18/57,20.07%,TDRD3;KDM7A;PYGO1;MTF2;MORC4;ZMYND8;WDR5;NCAPG2;RRP8;BPTF;MSH6;MSL3;MPHOSPH8;KDM4A;KDM8;PHF8;MORC3;ATRX
prerank,chloride channel activity (GO:0005254),0.32424792949546727,0.9302753934570149,0.5542929292929293,0.8989507609559432,1.0,15/59,21.18%,CLIC4;ANO6;GABRQ;BEST1;TTYH3;CLCN3;CLCN1;GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRB1;CLCN7;GABRB3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.40015537700180154,0.929898042781736,0.5392749244712991,0.8966545690232842,1.0,3/18,7.43%,PIK3R6;CISH;SOCS6
prerank,nucleotide diphosphatase activity (GO:0004551),-0.3646698509561529,-0.9289745454968948,0.5474254742547425,0.8613456789879216,1.0,3/14,5.60%,FHIT;NUDT4;ENPP1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.38237860267463025,0.9287112444781642,0.5440956651718983,0.89616910310761,1.0,8/22,20.39%,LANCL1;HSP90B1;AP2M1;CLU;MESD;LDLRAP1;SYT1;DNAJA1
prerank,G protein-coupled receptor activity (GO:0004930),0.2852065036677383,0.925223537514332,0.6477987421383647,0.9004585665458552,1.0,20/239,8.59%,ADGRL4;S1PR1;ADGRE5;F2RL1;ADRB2;RRH;LGR5;GPR157;QRFPR;MRGPRE;LANCL1;LPAR6;GPR143;HCRTR1;CMKLR1;NPR1;MC4R;MTNR1B;ADGRA1;ELOVL4
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2915183002570797,0.9240741079630768,0.6244588744588745,0.8998844042632671,1.0,31/181,14.30%,LDB2;LMO2;TBXT;TAL1;HNF4A;ACTN4;RBBP8;HEY2;KLF4;BBS7;COMMD7;GABARAPL1;STAT1;HSPB1;RBL1;NFE2L2;TCF3;JUN;DHX9;MAD2L2;NFKBIA;NPM1;HIF1AN;ACTB;DTX3L;DMAP1;HIF1A;TBX20;NFATC1;CTNNB1;DUSP26
prerank,signal sequence binding (GO:0005048),0.3559204802000548,0.9204654183324441,0.5774647887323944,0.9045921488507239,1.0,13/35,21.63%,AP2B1;TOMM20L;KPNB1;BABAM2;AP2M1;NFKBIA;NUP153;KPNA3;CABP1;PEX5L;BRAP;IPO4;KCNIP2
prerank,cation transmembrane transporter activity (GO:0008324),0.3359048584824841,0.9202564300960709,0.5771812080536913,0.902017744899342,1.0,4/48,8.67%,SLC6A6;SFXN1;SLC7A1;SLC15A4
prerank,GTPase inhibitor activity (GO:0005095),-0.3626783496603673,-0.9195503831897587,0.5634920634920635,0.8781274515767293,1.0,5/13,13.71%,SLIT2;IQGAP2;CPEB2;IPO5;RTKN
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.403329019286815,0.9169807446454792,0.5560747663551402,0.9061875947181517,1.0,4/16,19.44%,PIR;HGD;ALOXE3;CDO1
prerank,manganese ion binding (GO:0030145),0.3325383873840772,0.9169266161232827,0.5769230769230769,0.9032869247388735,1.0,11/48,11.78%,POMGNT1;MGAT5;ARG1;PCK2;EXD2;MTPAP;FEN1;ADPRM;MGAT1;XXYLT1;GALNT4
prerank,mRNA methyltransferase activity (GO:0008174),0.42933392833684725,0.9146257173921944,0.5504885993485342,0.9050817868868603,1.0,3/12,13.15%,TRMT61A;TRMT61B;METTL14
prerank,carbohydrate:cation symporter activity (GO:0005402),0.43214002683760744,0.9121253799592979,0.6,0.9073879570843673,1.0,2/11,8.57%,SLC5A10;SLC2A9
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.39205252715636546,-0.9115266642634645,0.5864864864864865,0.8915779547909588,1.0,5/10,19.44%,KDM7A;KDM4A;RIOX2;KDM8;PHF8
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3045009535530799,-0.9089023678463244,0.5923566878980892,0.8919942057316197,1.0,8/26,19.09%,AEBP1;CPE;AGBL3;CPXM2;CPXM1;AGBL1;ACE2;CPA6
prerank,ATP hydrolysis activity (GO:0140603),0.34070382465685256,0.9085594356930614,0.5753052917232022,0.9119065029322595,1.0,7/41,11.75%,MYO1E;DDX4;KIF26A;HSPA1B;DHX9;ABCG4;CLU
prerank,N-acetyltransferase activity (GO:0008080),0.3831811205759523,0.9079496799346178,0.5738724727838258,0.9101386080251976,1.0,1/19,1.42%,SATL1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3756272245234073,0.9077562558013491,0.5809379727685325,0.9075540707189459,1.0,8/24,22.44%,DAB2IP;PLEKHA5;CERT1;ARFIP2;GOLPH3L;GOLPH3;PLEKHA3;OSBPL5
prerank,lipase activity (GO:0016298),0.33483041204336284,0.9072061573283746,0.5961272475795297,0.9057291643231409,1.0,4/43,8.59%,PITPNM3;PNLIP;LCAT;ABHD6
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.3302794048768275,-0.9054383142932104,0.5877659574468085,0.8945917382095492,1.0,9/17,32.82%,AK5;CMPK2;AK1;NME2;NME6;NOL9;AK3;NME1;AK9
prerank,general transcription initiation factor binding (GO:0140296),0.3749956420084953,0.9047653041069355,0.5896700143472023,0.9079415262900523,1.0,10/25,18.45%,HHEX;BRF2;GTF2A1;TAF1B;PSMC1;PSMC5;TAF11;ESR1;DRAP1;RELA
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.3768665905294607,-0.8964925885294033,0.6060606060606061,0.9098458309095441,1.0,5/11,25.67%,NAA60;NAA40;NAA10;NAA50;NAA15
prerank,phosphatase inhibitor activity (GO:0019212),-0.3183143694690482,-0.8961232419749279,0.6169590643274854,0.904955751437684,1.0,3/20,4.35%,PTN;SET;BOD1L1
prerank,endopeptidase regulator activity (GO:0061135),0.3356358369296998,0.8950038844051962,0.6188524590163934,0.9254980474569091,1.0,11/40,22.29%,RECK;APH1A;SPINT2;VSIR;PSMD14;SLPI;CST3;PROS1;USP14;APH1B;A2M
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3758268822921158,-0.8936854638521737,0.5909090909090909,0.904758129891831,1.0,8/11,53.39%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,aminopeptidase activity (GO:0004177),-0.297923020462871,-0.887953197716462,0.6354515050167224,0.9120384737539461,1.0,7/26,13.76%,MMP14;ANPEP;METAP1D;MMP16;ENPEP;RNPEP;METAP1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3040296442788411,0.8867280154017383,0.6448828606658447,0.9395821191151784,1.0,7/70,8.09%,GCNT1;MFNG;POMGNT1;EXT1;GCNT2;POGLUT1;B3GNT3
prerank,E-box binding (GO:0070888),0.342818409233283,0.8858693014141904,0.6244665718349929,0.9382938444496823,1.0,5/34,9.04%,NEUROG2;TAL1;GATA3;SNAI2;TCF3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.42274487075167444,0.885210136261558,0.6013400335008375,0.9366281445947362,1.0,4/11,22.84%,SLC17A9;SLC35B3;SLC25A25;SLC25A42
prerank,thioesterase binding (GO:0031996),0.4209426931552565,0.883360791020698,0.6044142614601019,0.9374614418166315,1.0,2/11,10.32%,TRAF1;RAC1
prerank,Hsp90 protein binding (GO:0051879),0.3457320265669592,0.8828499901391641,0.6218130311614731,0.9355099546288311,1.0,8/33,19.55%,NOD2;UNC45B;UNC45A;PTGES3;HIF1A;AHSA1;PPID;ERN1
prerank,transcription corepressor binding (GO:0001222),-0.2957420466991702,-0.8820664519833831,0.6349693251533742,0.9198787238918091,1.0,8/27,17.62%,MTF2;LCOR;RORA;USP11;EHMT1;HDAC6;PER3;NEK6
prerank,protein kinase activator activity (GO:0030295),0.3103902078848348,0.8794492387921848,0.648171500630517,0.9392238789456971,1.0,15/60,19.81%,AFAP1L2;IQGAP1;MADD;IRGM;GPRC5A;GRM5;CALM3;MARK2;RICTOR;PAK2;DAXX;CD24;EPO;MAP2K1;CAB39
prerank,G protein-coupled receptor binding (GO:0001664),0.2886637510759904,0.8789534849918006,0.6759259259259259,0.937229670830766,1.0,10/132,8.07%,CCDC88C;S1PR1;ACE;GNAQ;GNAL;HOMER2;GNAI2;ARRB1;HSPA1B;REEP2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2740361164863272,-0.8755362181461972,0.6767676767676768,0.9290699178979009,1.0,11/34,18.08%,NSD3;EHMT1;SETD7;DOT1L;METTL21A;EEF1AKMT1;KMT5B;SUV39H1;SETD4;N6AMT1;EEF1AKMT2
prerank,RNA binding (GO:0003723),0.25967334247964996,0.8754407985233231,0.928,0.941112077905177,1.0,390/1321,24.72%,NANOS1;NANOS3;SORBS2;SYNE1;FASN;ESRP2;NOVA2;ZYX;FLNB;FKBP4;ADARB1;RBPMS;MACF1;IFIH1;LRRFIP1;VIM;MAP4;NPM3;BOP1;DHX32;DIAPH1;ACTN4;PELP1;KCTD12;TLR3;RPS21;RPL27;DDX4;TNS1;MSN;PUM2;CCDC9B;RBM7;SRP14;SUMO2;DHX37;MBNL1;ZCCHC9;SSBP1;KARS1;DDX39A;FNDC3B;DDX41;RPL7;MYEF2;PPIE;MRPL4;KHDRBS3;MEX3B;MYH9;ASS1;PHF6;APEX1;BUD13;RTF1;PABPC5;PSMD4;SETX;ENDOV;LSM1;TUBB4B;PLEC;ZC3H12A;HNRNPA0;MRPL41;ELAVL1;RANGAP1;EXOSC3;NGRN;HSP90B1;KPNB1;AATF;CTNNA1;CCDC124;HSPB1;HSPA1B;ATP5F1A;PURA;MTPAP;ZNF346;NVL;SCAF4;DCP1B;ZC3H7A;DNAJC2;OAS2;U2SURP;MRPL1;RPS27A;MRPS31;DDX28;RPS14;POLR2G;RBM28;RPL35;ETF1;CACTIN;ADAR;EIF3B;DSP;JUN;ZFP36L2;WDR46;HMGB1;HSPE1;RTN4;DHX9;MRPL15;RPL21;EIF1AX;EIF1;CELF4;DKC1;DUSP11;POLR2D;FARS2;RPL37;TASOR;TRIM25;ARHGEF1;HNRNPK;RPS28;CNOT1;PTPN1;PRPF38A;LARP1B;TUFM;AGO4;GTPBP1;RPL34;RPS9;FIP1L1;ASCC3;PTBP3;XRN2;NHP2;NPM1;PCBP1;CAVIN1;EEF2;ALKBH8;RPS25;TIAL1;DHX40;EIF3I;BRCA1;TRMT2A;MRPL23;ILF2;VIRMA;RBM11;HELZ2;MARK2;GLRX3;CHTOP;XRN1;GCN1;RPL30;EIF3G;NUFIP2;SMNDC1;SRSF9;METAP2;CCT4;FBLL1;AKAP1;RPL27A;RPS5;MSI2;GPATCH4;NOL8;METTL14;FXR1;HABP4;SRP9;RBM45;RPP38;HNRNPH2;DDX56;DDX21;HMGB2;COL14A1;NOL3;CLNS1A;FASTKD5;MRPL14;MRPL32;SART1;PSMC1;RPL23A;CCT6A;TFB2M;MRPS12;MAP3K20;NUP42;RAN;TRMT10B;SYF2;RPS15;SRPRA;EIF3A;SF3B4;CRNKL1;ELAVL2;EIF2A;EIF2S1;YBX1;EIF3H;PIN4;EDC3;MTIF2;RPL19;RPS18;FAU;DDX6;DDX55;TEFM;UBFD1;RACK1;MRPL39;PKN2;PTCD2;SF3A1;SLPI;RPL32;RBM15;SPEN;TCOF1;DHX38;ELAC2;HADHB;TMSB4X;UTP18;ATXN2L;RPL22L1;SAFB2;DROSHA;RPL37A;SRPK1;POP1;RPL18A;TRNAU1AP;MRPL54;RPL7L1;SEPSECS;POLDIP3;LRPPRC;EXD1;UNC50;TUT7;SPTBN1;NSUN5;DXO;LSM14B;EXOSC9;RSRC2;KHNYN;TRMT1L;CCDC47;NOL4;LAS1L;DDX39B;SRP19;RPUSD2;TIA1;ZC3H15;MKRN1;HNRNPUL1;DDX47;TDRD9;NAP1L4;FTSJ3;CSTF2;PTBP2;G3BP1;MRM3;SYNCRIP;DCAF13;SF3B6;LSM2;SMG7;ZC3HAV1;BARD1;DARS1;MYO18A;IBA57;MRPS30;MKRN2;PA2G4;GFM1;CPSF3;ZC3H8;PPHLN1;ANG;RRP9;NOL7;DHX58;ACAA2;BAG4;YTHDC1;EIF2AK2;STAU2;MRPL11;RCAN3;SF3B2;ANKRD17;TRMT1;PWP2;RSL24D1;MBNL2;RPL18;UBA1;ZFP36L1;HEXIM1;C1D;MTCL1;ZCCHC17;RPL39;NOLC1;IMP4;MRPS28;MRPS35;SF3A3;FAM50A;NSUN6;EXOSC10;CRKL;RPS19;LRRC47;CSDE1;NSRP1;RPL31;SEC63;EXOSC1;JAKMIP1;MRPS9;FBL;RPS8;ZNF106;MEX3D;MRPS27;UBAP2;RTCA;NOP53;NQO1;TBRG4;TOP3B;URB1;KIN;RPF2;RAE1;POLR2B;EIF4G1;DHX57;CNBP;ZNF638;EDF1;NUDT16;DHX36;IREB2;TYW5;PATL2;CPNE3;ZCRB1;TCP1;HLTF;TSFM;OASL;ZNF326;MYO5A;CCT3;WDR43;PRPF40B;TUBA1B;USO1;RBFOX1;RPL3;UBE2O;LRRC59;RNASEH1;UTP20;FRG1;CANX;ANXA11;OTUD4;MRTO4;EIF4ENIF1;ALYREF;RIMS1;APTX
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4033055003638085,0.8752901128277824,0.587171052631579,0.9384015327669895,1.0,3/13,8.67%,SLC7A7;SLC7A1;SLC15A4
prerank,nuclear import signal receptor activity (GO:0061608),-0.33575512350896886,-0.874105994452781,0.6640625,0.9262836416763753,1.0,5/15,14.65%,KPNA1;TNPO3;RANBP6;IPO5;TNPO2
prerank,thyroid hormone receptor binding (GO:0046966),-0.2850461674498393,-0.8712534291734599,0.709375,0.9268436886277859,1.0,10/28,19.66%,TRIP12;TACC1;NSD1;MED13;JMJD1C;GTF2B;MED16;TAF7;GTF2H1;GAS2L1
prerank,cation:chloride symporter activity (GO:0015377),-0.3763038018272602,-0.8687139590641418,0.6503667481662592,0.9267739718244967,1.0,2/10,5.85%,SLC12A2;SLC6A1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3309134171959107,0.8684785283009778,0.6239782016348774,0.9491959609009335,1.0,4/38,8.18%,HIP1;DAB2IP;TECPR1;PLEKHA5
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.29978786055303647,-0.8669959825054371,0.6189024390243902,0.924769832082115,1.0,7/20,17.49%,UFSP2;SENP3;USP9X;USP50;SENP1;OTULINL;SENP2
prerank,DNA replication origin binding (GO:0003688),0.3563578630333846,0.8667675810425363,0.6194029850746269,0.9497054194086861,1.0,5/23,15.02%,ORC3;DHX9;POLA1;ORC5;KAT7
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4010457543431708,0.8655403700648351,0.6316666666666667,0.9492151213122473,1.0,6/13,17.83%,SH3BP4;ARHGDIA;CCDC88A;RANBP1;ITGB1BP1;GDI1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.35531780766422766,-0.8635569364195498,0.6419437340153452,0.9266565179021902,1.0,4/12,21.34%,DHRS4;AIFM2;NDUFS7;CRYZ
prerank,zinc ion binding (GO:0008270),0.26221290110897594,0.8580323059017825,0.7805383022774327,0.961013834733289,1.0,38/293,11.69%,MYRIP;ACE;GDA;CRIP2;ARHGEF2;DUSP12;MSRB3;KLF7;IFIH1;GCH1;KLF4;LANCL1;TNFSF10;RNF125;SHANK3;ARIH1;SMPDL3A;ASAH2;PGGT1B;TRIM24;CLIP1;KPNB1;MT2A;PLSCR1;GRIN2B;KMT2B;CAD;MBD1;EGR1;DHH;PTPN1;TET3;TNKS;TAB2;HIF1AN;ALKBH8;SAP30L;TRIM8
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.22064068658863517,-0.8570093426321271,0.8,0.9347965130169198,1.0,25/83,22.55%,USP33;USP20;USP9X;USP13;USP11;USP50;USP1;USP3;OTUD6B;OTUD7B;MINDY3;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;USP34;VCPIP1;JOSD2;USP46;USP2;USP31;TNFAIP3
prerank,store-operated calcium channel activity (GO:0015279),0.4179248774863375,0.8529108426129458,0.6348408710217756,0.9681143581419248,1.0,4/10,14.50%,ORAI1;STIM2;TRPC7;TRPC5
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4039707101376637,0.8527151561498086,0.6466552315608919,0.9655063259551984,1.0,2/12,7.08%,SLC17A9;SLC35B3
prerank,protein kinase C activity (GO:0004697),0.38916096383256593,0.850163133469226,0.6349453978159126,0.9674833959219028,1.0,3/14,10.36%,PRKD1;PKN1;PRKCG
prerank,carboxypeptidase activity (GO:0004180),-0.2637900715066161,-0.8501264164517757,0.7412587412587412,0.9437853884622304,1.0,9/35,19.09%,AEBP1;CPE;AGBL3;NAALAD2;CPXM2;CPXM1;AGBL1;ACE2;CPA6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.42335016559178923,0.8500221814648609,0.6722972972972973,0.9647673865504042,1.0,1/10,1.76%,GDA
prerank,potassium channel regulator activity (GO:0015459),0.3134027401285474,0.8482859171641892,0.6814044213263979,0.965304708554184,1.0,7/49,12.29%,KCNE3;ADRB2;DPP6;DPP10;SGK1;NEDD4L;ARPP19
prerank,hexosyltransferase activity (GO:0016758),0.27977681286749756,0.8458917301860472,0.7343565525383707,0.9670256308695787,1.0,9/101,8.09%,GCNT1;MFNG;POMGNT1;B4GALT4;EXT1;GCNT2;POGLUT1;A4GALT;B3GNT3
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.2984853519613407,-0.8452814227768777,0.6870026525198939,0.9484117628221048,1.0,7/20,24.85%,CASK;AK6;MAGI3;CMPK2;AK1;LRGUK;DLG1
prerank,NF-kappaB binding (GO:0051059),0.3415965229185354,0.842568526757021,0.6626865671641791,0.9704782249716967,1.0,8/24,25.88%,COMMD7;NFKBIA;NPM1;HIF1AN;RELA;GSK3B;RNF25;HDAC2
prerank,bHLH transcription factor binding (GO:0043425),-0.3080249818608417,-0.8420504791468549,0.6920821114369502,0.9494426530736381,1.0,4/19,10.88%,FHL2;CREBBP;SMAD3;BHLHE41
prerank,hormone receptor binding (GO:0051427),0.3781231806727566,0.8416692437214365,0.6427432216905901,0.96930079515618,1.0,3/14,18.59%,JAK2;NPPC;NCOA6
prerank,ionotropic glutamate receptor binding (GO:0035255),0.40821057811499245,0.8415220208216748,0.6186440677966102,0.9666500881109784,1.0,4/10,19.82%,SHANK3;SHISA6;NSF;SHANK2
prerank,steroid hydroxylase activity (GO:0008395),0.3752517153250773,0.8383085553817532,0.6572327044025157,0.9697689944490021,1.0,1/16,2.23%,CYP39A1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.2747450148896334,-0.8377978129089321,0.7216828478964401,0.9520199610251472,1.0,4/31,6.26%,SLC12A2;KCNK5;ABCC9;KCNQ4
prerank,GDP binding (GO:0019003),0.29078498495717536,0.837586615787148,0.7267080745341615,0.9682460520766324,1.0,18/63,21.84%,NRAS;KRAS;RRAS;RAB35;RRAS2;RHEBL1;RRAGD;RAN;RHEB;RAB27B;RIT2;RAB27A;RAB5C;RRAGC;RAB31;RAB12;RALB;RAP1B
prerank,voltage-gated cation channel activity (GO:0022843),0.28000452480907173,0.8346722509774572,0.7523364485981309,0.9709606891161257,1.0,18/97,18.18%,KCNQ1;KCNH8;CACNA1A;KCNG3;GRIN2B;KCNC1;GRIN2C;KCNH7;TPCN2;GRIN3A;KCNC4;KCNA1;CACNA1E;KCNC2;GRIN2A;KCNH1;KCNH5;KCNQ3
prerank,semaphorin receptor activity (GO:0017154),0.392810999519549,0.8345298207379724,0.6463620981387479,0.9682959652222785,1.0,2/11,3.85%,PLXNA4;PLXND1
prerank,retinoid X receptor binding (GO:0046965),0.3968438747460069,0.8342539487600917,0.6481481481481481,0.9659237165266598,1.0,2/11,9.35%,NR4A2;ARID5A
prerank,carboxylic ester hydrolase activity (GO:0052689),0.28666195832759167,0.8340529838488148,0.7198538367844093,0.9633886063661083,1.0,23/85,24.21%,AOAH;PNLIP;LCAT;PGAP1;PNPLA6;APMAP;ABHD6;GDPD1;ACHE;PON2;PON3;ABHD2;PLA2G12A;PLAAT3;BCHE;PNPLA2;ABHD4;LYPLAL1;LYPLA1;ESD;GDE1;MGLL;GDPD3
prerank,ribonuclease activity (GO:0004540),0.30200525260463557,0.8334165754499222,0.7174193548387097,0.9616353366523603,1.0,22/56,24.34%,INTS11;ZC3H12A;EXOSC3;RNASE1;EXOSC8;RNASE6;EXOG;ELAC2;RNASE12;EXOSC9;NOB1;KHNYN;ERN1;CPSF3;ANG;RNASE4;EXOSC10;DIS3L2;EXOSC1;RNASE7;RNASEH2A;RNASEH1
prerank,poly(A) binding (GO:0008143),-0.2947971905584911,-0.8328551700232675,0.7134328358208956,0.9565599892769393,1.0,2/21,1.52%,RBMS3;RBMS1
prerank,MAP-kinase scaffold activity (GO:0005078),0.40247715758669256,0.8321183589150607,0.6704180064308681,0.961049281865437,1.0,2/11,5.60%,IQGAP1;SPAG9
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.21931649200756226,-0.8290841831028523,0.84375,0.9584195622070028,1.0,30/73,34.24%,LGR4;NPR3;EDNRA;SORCS2;BDKRB2;SORCS3;PTH1R;CYSLTR1;EDNRB;CYSLTR2;GPR37L1;GLP2R;OPRK1;MC5R;APLNR;VIPR2;CCKBR;CALCRL;NPSR1;TSHR;GALR1;LHCGR;F2R;GPR37;S1PR2;GRPR;PTH2R;KISS1R;GIPR;MAS1
prerank,lipoprotein particle receptor binding (GO:0070325),0.3291325392740697,0.8289119394811232,0.6751412429378532,0.9639786296057988,1.0,7/27,14.27%,APOA1;LANCL1;HSP90B1;AP2M1;CLU;MESD;LDLRAP1
prerank,poly-purine tract binding (GO:0070717),-0.27554157382089123,-0.8287739556943787,0.7408637873754153,0.9534339928590463,1.0,13/27,28.46%,RBMS3;RBMS1;DAZAP1;DDX1;DDX3X;HNRNPU;PABPC1;PABPC4L;EIF4A3;KHDRBS1;HNRNPDL;PNPT1;LARP4
prerank,lipase activator activity (GO:0060229),0.4030998407917191,0.8280394413849782,0.6621160409556314,0.9628729172893995,1.0,3/10,12.94%,FYN;BTK;APOH
prerank,chemokine activity (GO:0008009),-0.25739853995179074,-0.8257468274592191,0.7406143344709898,0.953657047143757,1.0,22/31,51.47%,CXCL16;CCL25;CKLF;CCL19;CXCL12;CCL2;CCL14;CCL28;CX3CL1;CCL5;PF4;PPBP;CCL8;CXCL5;CXCL1;CCL7;CCL1;CCL3;CCL11;CCL13;CXCL13;CXCL2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.37237583552085696,0.8242340931279065,0.647912885662432,0.9666946645486054,1.0,4/13,23.63%,DDT;ECI1;SREBF2;IDI1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.35909866234120824,0.823118215691284,0.6953125,0.9630028987420806,1.0,2/16,7.65%,ANO6;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),0.35909866234120824,0.823118215691284,0.6953125,0.9630028987420806,1.0,2/16,7.65%,ANO6;TTYH3
prerank,nuclear localization sequence binding (GO:0008139),0.3594381595891584,0.8224579906169882,0.6751188589540412,0.96134038718957,1.0,7/18,21.08%,KPNB1;NFKBIA;NUP153;KPNA3;CABP1;BRAP;IPO4
prerank,motor activity (GO:0003774),0.2895317248808063,0.8205387289149919,0.7379746835443038,0.961744949339789,1.0,11/60,15.82%,MYO1E;KIF26A;MYH9;KIF2A;MYL6;STARD9;KIF26B;PIN1;KIF24;KIF16B;KIF1A
prerank,diacylglycerol kinase activity (GO:0004143),0.3903628495120398,0.8195966391428167,0.6700167504187605,0.9605663141019831,1.0,4/11,20.24%,DGKH;AGK;DGKI;DGKA
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3257631786750005,-0.8156483397283957,0.7007672634271099,0.967636296439354,1.0,2/13,4.86%,AGPAT4;LPCAT2
prerank,ubiquitin-specific protease binding (GO:1990381),0.34239377787604414,0.8156180542861852,0.7007633587786259,0.9649381757089934,1.0,3/19,12.80%,SPATA2;BAG6;CHMP3
prerank,magnesium ion binding (GO:0000287),0.26201375309544167,0.8141570909799447,0.7848383500557413,0.9646284527924048,1.0,44/135,24.48%,SNRK;CDC42BPA;OXSR1;MAP3K6;CDC42BPG;STK38;STK38L;NLK;ENDOV;EXD2;THTPA;MAST1;LRRK2;SIK2;MTPAP;PLSCR1;FEN1;XXYLT1;GSS;MARK2;MAP3K20;RAN;RHEB;SRPK1;CIB2;DXO;PLSCR3;RRAGC;ERN1;AASDHPPT;CDC42BPB;DIS3L2;NT5C3A;ABL2;GEN1;MVK;NUDT16;DHX36;BRSK2;IDH3G;PPA2;WRN;MTHFD2;TESC
prerank,dynactin binding (GO:0034452),-0.32382142443947826,-0.8121509234483596,0.7279596977329975,0.9688923914198685,1.0,3/12,20.01%,SNX6;BICD2;SNX5
prerank,histone methyltransferase binding (GO:1990226),0.39231581265884846,0.810580706077029,0.7030716723549488,0.9679047317735123,1.0,3/11,16.49%,LCORL;CTNNB1;CBX1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.27491827726826673,0.8090974056015122,0.7539585870889159,0.9675743555070796,1.0,20/78,21.80%,CASP8;USP38;CASP2;CASP1;USP12;CAPN5;USP29;USP9Y;CASP7;PYCARD;USP35;CTSO;CTSK;CAPN1;MALT1;CTSH;USP47;USP14;CAPNS1;USP30
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3491760627624929,-0.8071372401987552,0.6943127962085308,0.9726808925997243,1.0,4/10,9.12%,DPP4;FAP;PRCP;NAALAD2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.281243020733385,0.8032818593958515,0.7493765586034913,0.9750483202476908,1.0,11/60,14.73%,DUSP1;LRRC39;PPM1F;LRRK2;PPP3CA;PP2D1;CDC14A;PDP1;PPM1D;PPM1L;PPP2CB
prerank,MAP kinase activity (GO:0004707),-0.31497336837176715,-0.8005025011465997,0.713216957605985,0.979372925581296,1.0,2/14,7.35%,MAPK4;MAPK6
prerank,phospholipase A2 activity (GO:0004623),-0.2639971334477609,-0.7984878959265237,0.8053892215568862,0.9773913487830278,1.0,16/26,49.48%,PLA2G4A;PLA2G15;PLA2G6;PLA2G4C;PLA2G7;PLA2G4F;PLAAT1;PLA2G4B;PLA2G5;PLB1;ABHD3;PLA2G3;PLAAT5;PNPLA3;PLA2G4E;PLA2G2C
prerank,estrogen receptor binding (GO:0030331),0.3114379161676921,0.7964546188552576,0.7480106100795756,0.9836873087019229,1.0,12/32,19.13%,LEF1;SRARP;ARID5A;CNOT1;CTNNB1;ESR1;MMS19;STRN;PPID;NCOA6;DCAF13;WBP2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.2537742780289203,-0.7942664853854995,0.8238993710691824,0.979152307964439,1.0,8/31,17.09%,UBE2E2;UBE2N;TAF1;BIRC6;UBE2L3;UBE2G2;UBE2L6;UBE2QL1
prerank,GABA receptor binding (GO:0050811),0.3730449464973916,0.7927471794285584,0.6998341625207297,0.987159448286844,1.0,2/11,6.27%,AKAP5;GABARAPL1
prerank,ubiquitin binding (GO:0043130),-0.20222807537886703,-0.7911633900909673,0.9025974025974026,0.9789287743689001,1.0,24/73,24.05%,PRKN;USP33;UBE2N;SMAD3;USP13;UBXN7;RNF31;UBXN2B;DNAJB2;TSG101;UCHL1;MDM2;SHARPIN;OTULINL;SIRT2;UBE2L6;UBAP1;RNF168;TNFAIP3;UBXN11;TOLLIP;GGA3;TOP2A;MVB12B
prerank,ADP binding (GO:0043531),-0.26615606478381026,-0.79025895005769,0.7914110429447853,0.9749345353642681,1.0,5/25,13.18%,PRKAG2;ME1;GCLC;MYO9B;MSH6
prerank,beta-tubulin binding (GO:0048487),0.3103383550562407,0.7898982027342855,0.7572674418604651,0.9891550200615471,1.0,4/31,9.15%,TRPV4;TTLL7;GABARAPL1;UXT
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3116924044636317,-0.787567260910941,0.7401129943502824,0.9739546305007205,1.0,4/12,19.44%,KDM7A;JMJD1C;KDM4A;PHF8
prerank,hormone activity (GO:0005179),0.2841381907226696,0.7875063265957756,0.7764705882352941,0.9902083297895125,1.0,4/54,11.54%,EDN1;GAL;APLN;NPPC
prerank,deoxyribonuclease activity (GO:0004536),0.3598735297116325,0.7856172949844908,0.6998313659359191,0.9906532265330196,1.0,3/14,13.91%,APEX1;DFFB;ERCC4
prerank,histone methyltransferase activity (GO:0042054),-0.248986604448634,-0.7849449152456861,0.8052805280528053,0.9729506112925037,1.0,8/32,16.24%,KMT2C;NSD3;EHMT1;SETD7;DOT1L;KMT5B;SUV39H1;N6AMT1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3588437606565966,0.7848989478204346,0.7094017094017094,0.9891239518341561,1.0,5/14,28.07%,CAPN5;CAPN1;CAPNS1;CAPN2;CAPN10
prerank,mRNA binding (GO:0003729),0.23930012485157226,0.7808003712582161,0.8924843423799582,0.9931721849080484,1.0,26/249,11.28%,NANOS1;NANOS3;ESRP2;NOVA2;ADARB1;RBPMS;PUM2;RPL7;MYEF2;PPIE;KHDRBS3;PABPC5;ZC3H12A;HNRNPA0;ELAVL1;DCP1B;RPS14;RPL35;ETF1;ELAVL4;DHX9;CELF4;HNRNPK;PTBP3;ANGEL2;PCBP1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3312337694765065,-0.7799238150225555,0.7284263959390863,0.9760790023006212,1.0,1/11,0.37%,EGFR
prerank,ion gated channel activity (GO:0022839),-0.2593884623098648,-0.7773588380564088,0.8312883435582822,0.9747643293270108,1.0,3/24,8.09%,KCNT2;ANO1;KCNT1
prerank,cholesterol transfer activity (GO:0120020),0.34624853180161075,0.7773292598102715,0.7613814756671899,0.9961876021002432,1.0,2/16,5.40%,APOA1;PLTP
prerank,nuclear receptor binding (GO:0016922),0.2541516278531,0.7758088516302014,0.8463302752293578,0.9958499307728442,1.0,29/111,19.35%,NR4A2;ACTN4;LEF1;SRARP;PKN1;BRD8;STAT1;KDM3A;FOXP1;ARID5A;CNOT1;NR4A1;MED30;YWHAH;HIF1A;CTNNB1;MED17;MED4;TAF11;ESR1;DAXX;MMS19;STRN;PPID;NCOA6;CRY1;DCAF13;WBP2;NCOA7
prerank,voltage-gated chloride channel activity (GO:0005247),0.36649127631485673,0.7756286216879895,0.7123519458544839,0.9933537314576,1.0,3/10,10.34%,ANO6;CLCN3;CLCN1
prerank,sterol transfer activity (GO:0120015),0.3422640133498338,0.7741972323667475,0.7705696202531646,0.9929019018247891,1.0,2/17,5.40%,APOA1;PLTP
prerank,telomeric DNA binding (GO:0042162),0.3022177495208603,0.7733991860038449,0.7677329624478443,0.9914132470902468,1.0,12/32,25.72%,HMBOX1;ZBTB48;APEX1;PURA;STN1;CTC1;TERF2IP;SMG7;BLM;TERF2;WRN;TINF2
prerank,copper ion binding (GO:0005507),0.2891048976847067,0.7730772094024426,0.7896138482023968,0.9892150402740117,1.0,12/42,22.49%,ATOX1;SNCG;ATP7A;IL1A;PRNP;TYR;CUTA;HEPH;ATP7B;ANG;CCS;SOD1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.37602373921418536,0.7725511740796714,0.7172413793103448,0.9874215233870111,1.0,6/10,20.69%,SETD3;ASH1L;NSD2;SETD2;PRDM9;SMYD2
prerank,epidermal growth factor receptor binding (GO:0005154),0.3112232947278707,0.7719887017108638,0.7296137339055794,0.9855978813142053,1.0,3/25,10.46%,HIP1;PLSCR1;CCDC88A
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.23370401335454438,-0.7711138764833523,0.8469750889679716,0.9742105335455826,1.0,14/34,27.26%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFB10;NDUFS6;NDUFS7;NDUFA1;NDUFB8;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.23370401335454438,-0.7711138764833523,0.8469750889679716,0.9742105335455826,1.0,14/34,27.26%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFB10;NDUFS6;NDUFS7;NDUFA1;NDUFB8;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.279160248098057,0.7672105957533624,0.7989556135770235,0.9903663532229986,1.0,7/51,9.64%,SLC25A16;SLCO1C1;SLC35D2;SLC35E4;SLC16A2;CLCN3;SLC25A30
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2884663710467995,0.767175425918504,0.7888111888111888,0.9877446282044418,1.0,9/38,16.96%,SPATA2;CARD10;SPAG9;SHANK3;LRRK2;STAP1;LDLRAP1;NCK1;MMS19
prerank,nucleotidyltransferase activity (GO:0016779),-0.27496213638021694,-0.7647975803968857,0.7948717948717948,0.9791752219342177,1.0,10/19,27.42%,CRPPA;REV1;TENT4B;TUT1;TERT;TUT4;PAPSS2;CGAS;MOCS3;PNPT1
prerank,O-acyltransferase activity (GO:0008374),0.30102277693928237,0.7623872752673083,0.7722627737226277,0.9925632467008721,1.0,5/30,10.93%,MBOAT2;LPCAT4;LCAT;LPCAT3;MOGAT1
prerank,protein kinase inhibitor activity (GO:0004860),-0.22559628178149058,-0.7616784139701441,0.860655737704918,0.9784227207808198,1.0,12/42,20.22%,PARVA;DNAJC3;DUS2;SPRED1;GMFB;SH3BP5;SPRED2;QARS1;CDKN1A;PRKRIP1;IBTK;CIB1
prerank,sulfotransferase activity (GO:0008146),0.2952357248770174,0.7588879060631322,0.7917261055634808,0.9950688814145772,1.0,4/33,6.76%,HS3ST1;CHST14;SULT6B1;CHST11
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.30432601374211593,0.7553625656066212,0.7800289435600579,0.9978894119449814,1.0,11/30,23.23%,ATP7A;SLC31A1;SLC30A1;SLC39A6;SLC25A28;SLC30A3;ATP7B;SLC39A3;SLC30A4;SLC39A12;TTYH1
prerank,deubiquitinase activity (GO:0101005),-0.18936637889380006,-0.7547287926991887,0.9691358024691358,0.9837937300544213,1.0,23/88,20.43%,USP33;USP20;USP9X;USP13;USP11;USP50;USP1;USP3;OTUD6B;OTUD7B;MINDY3;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;USP34;VCPIP1;JOSD2;USP46;USP2
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.29288470723902227,-0.7540606441321183,0.7911227154046997,0.9795271527883881,1.0,7/14,32.82%,AK5;CMPK2;AK1;NME2;NME6;NME1;AK9
prerank,alpha-actinin binding (GO:0051393),0.3043994986171401,0.7525217261552548,0.7612809315866085,0.9993635559479785,1.0,2/24,4.50%,MAGI1;PDLIM5
prerank,death receptor binding (GO:0005123),0.3354898364155358,0.7509114079870408,0.7616747181964574,0.9990788018977099,1.0,3/15,11.08%,DAB2IP;MADD;CASP8AP2
prerank,NADPH binding (GO:0070402),-0.297893847916993,-0.7495821783875435,0.7877237851662404,0.9809198852018735,1.0,6/13,27.52%,DUS2;NDOR1;CRYZ;CBR3;GRHPR;DHFR
prerank,protein kinase regulator activity (GO:0019887),0.25218181011151053,0.7490332914012853,0.860381861575179,0.9992178091217098,1.0,20/95,19.81%,CCNY;CCND2;CCND3;CCNE1;SMCR8;MADD;ELP4;GPRC5A;APC;NPM1;MARK2;SPRY4;SH3BP5L;CSNK2B;NCK1;DAXX;CXCL10;EPO;ELP3;CAB39
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.2288760067372991,-0.7464049584877482,0.8702290076335878,0.9804215853560293,1.0,10/35,17.21%,RRN3;SMARCB1;TAF4;TAF1;DR1;HDAC1;GTF2B;PIH1D1;POU2F1;UBTF
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.251881016992779,-0.745472622545772,0.834983498349835,0.976627083201587,1.0,13/27,28.55%,PPARA;PRKN;DCUN1D3;ARIH2;UBE3D;RNF180;DCUN1D4;SIAH1;ZMYM2;TOLLIP;FOXL2;SIAH3;AUP1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.3588091318101049,0.7434752766197329,0.773356401384083,1.0,1.0,3/11,14.50%,ITPR3;TRPC7;TRPC5
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3438985424791402,0.7421758682912613,0.7585089141004863,1.0,1.0,7/12,26.32%,STAT1;TBPL1;GTF2A1;RELA;H3-3A;FOS;RUVBL2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3061785786593376,0.7420732997305507,0.7901049475262368,1.0,1.0,7/22,10.91%,CPSF1;ZC3H12A;HNRNPA0;ELAVL1;ELAVL4;ZFP36L2;EXOSC8
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.2787985775356419,-0.7404269880826884,0.8284960422163589,0.9785034714836374,1.0,5/15,36.59%,PLA2G4A;PLA2G4C;PLA2G4F;PLA2G4B;PLA2G5
prerank,hyaluronic acid binding (GO:0005540),0.3599798683115093,0.7395292191161958,0.7694974003466204,1.0,1.0,2/10,5.67%,HYAL2;LAYN
prerank,lysophospholipase activity (GO:0004622),-0.2644635650275143,-0.7394288546605507,0.8273809523809523,0.9748008269716274,1.0,7/20,20.71%,PLA2G4A;PNPLA7;ASPG;ABHD12;PLA2G6;ENPP2;PLA2G4C
prerank,glutathione transferase activity (GO:0004364),0.30121119035778565,0.7373994109168016,0.7870778267254038,1.0,1.0,2/23,4.86%,GSTA2;LANCL1
prerank,four-way junction DNA binding (GO:0000400),0.3281176199268978,0.7370808969960284,0.7935483870967742,1.0,1.0,7/17,24.24%,HMGB1;HMGB2;RAD51D;MEN1;BLM;GEN1;WRN
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.2758719665534274,-0.7364274072994987,0.8268156424581006,0.973540374892488,1.0,8/17,33.97%,DPYD;BDH2;BLVRB;PTGR1;SRD5A3;PECR;MECR;PTGR2
prerank,proton transmembrane transporter activity (GO:0015078),-0.2191420573026352,-0.7348569995942369,0.9192307692307692,0.9706136428739985,1.0,11/39,21.74%,ATP6V1B2;CLCN5;COX10;DMAC2L;UQCRQ;COX7A2L;CLCN4;UQCRH;SLC9A1;SLC11A2;ATP6V1F
prerank,nuclease activity (GO:0004518),0.26591059855272525,0.7339275652004824,0.8578878748370273,1.0,1.0,18/52,25.39%,APEX1;ZC3H12A;PLSCR1;DFFB;FEN1;RNASE1;XRN2;RNASE6;EXOG;RNASE12;ANG;RNASE4;DIS3L2;RNASE7;RNASEH2A;WRN;RNASEH1;ISG20L2
prerank,sodium channel activity (GO:0005272),0.27609597459320245,0.7327119936607984,0.8262068965517242,1.0,1.0,8/37,18.14%,SCN11A;SCN1B;ASIC2;GRIK5;GRIK2;SCN9A;GRIK1;SCN1A
prerank,protein phosphatase regulator activity (GO:0019888),0.26967808188878845,0.7323294749896112,0.8469259723964868,0.9992323489316416,1.0,24/53,25.48%,MGAT5;PPP1R16B;SHOC2;LMTK2;PPP2R5C;PPP2R2C;CALM3;ARPP19;PPP4R1;RCAN2;PPP1R15B;BOD1;PPP1R16A;PPP1R9B;PPP1R7;PPME1;EIF2AK2;RCAN3;PPP2R5E;IGBP1;PPP1R15A;PPP2R2A;LGALS3;PPP2R1A
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.33637638854399876,0.731368732740217,0.766497461928934,0.9979687039986866,1.0,3/12,17.34%,CNOT6L;CNOT1;CNOT2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.22920433560987363,-0.7295544787310854,0.9013605442176871,0.9723917990216848,1.0,8/34,17.09%,UBE2E2;UBE2N;TAF1;BIRC6;UBE2L3;UBE2G2;UBE2L6;UBE2QL1
prerank,glucuronosyltransferase activity (GO:0015020),0.3082710629756872,0.722785200809868,0.8173076923076923,1.0,1.0,2/19,9.09%,EXT1;B3GAT2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3235669635757089,0.7211313908370517,0.7832817337461301,1.0,1.0,4/16,22.84%,SLC44A1;SLC22A5;SLC29A4;SLC25A42
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.31386880015904417,-0.7194114803518549,0.8286384976525821,0.9795849300262489,1.0,4/10,25.67%,NAA60;NAA10;NAA50;NAA15
prerank,ubiquitin protein ligase activity (GO:0061630),0.21913815930996894,0.7180845127685538,0.9430979978925185,1.0,1.0,34/228,15.22%,TRIM14;ZNRF1;TRIM69;CBL;HERC2;TRIM11;TRIM6;RNF38;RNF125;RNF185;ARIH1;CUL3;UBE2D1;TRIM24;UBE4A;WWP1;UBE3A;SIAH2;RNF115;ZNRF3;RNF128;RBX1;TRIM25;RNF144B;TRIM17;NEDD4L;DTX3L;SMURF1;FBXO2;UBE3B;UBE2D3;NHLRC1;TRIM2;IRF2BP1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.24294450552789204,-0.7151324162174011,0.8776758409785933,0.9799638593899488,1.0,7/24,20.93%,CCT5;DDX3X;LARP1;NCL;LARP6;MRPS11;GNL3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2720941281053397,-0.7143496863742955,0.8595505617977528,0.9760221926938556,1.0,2/15,4.86%,AGPAT4;LPCAT2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.28573755868939427,0.712700745043432,0.827536231884058,1.0,1.0,12/28,26.35%,LRRK2;SGK1;PRKCG;RPS6KA1;RPS6KB1;MAPK14;MAP2K1;MAPKAPK5;MAP3K9;TNK2;MAP2K4;MAPKAPK3
prerank,hexosaminidase activity (GO:0015929),0.3397435569339039,0.7117128042096167,0.8134453781512605,1.0,1.0,2/12,5.46%,CEMIP2;HYAL2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.19974622841880885,-0.706962823814112,0.9414414414414415,0.9794809675956188,1.0,14/49,22.55%,IKBKE;TAB3;OPTN;PRPF8;ABRAXAS2;OTUD7B;HDAC6;SHARPIN;WDR81;ZRANB1;ZRANB3;RNF168;ZFAND2B;TNFAIP3
prerank,DNA polymerase binding (GO:0070182),0.30658295319820555,0.7052244568656854,0.8187599364069952,1.0,1.0,3/18,11.12%,HMGB1;PTGES3;POLG2
prerank,histone deacetylase activity (GO:0004407),0.3003839448555514,0.7046286723165959,0.8360413589364845,1.0,1.0,2/19,5.34%,HDAC9;HDAC11
prerank,cysteine-type peptidase activity (GO:0008234),0.23995282132935133,0.7030863524933766,0.8996328029375765,1.0,1.0,17/73,21.80%,CASP8;USP38;CASP2;TINAGL1;CASP1;USP12;USP29;USP9Y;CASP7;USP35;CTSO;CTSK;MALT1;CTSH;USP47;USP14;USP30
prerank,transaminase activity (GO:0008483),-0.29540316353590135,-0.7023944176160677,0.8461538461538461,0.9796986396080027,1.0,4/11,20.77%,ABAT;OAT;GOT1;AGXT
prerank,RNA stem-loop binding (GO:0035613),-0.2806564380302038,-0.7020622202920846,0.8602941176470589,0.9751734950288401,1.0,5/12,19.45%,EPRS1;CPEB3;DDX3X;RC3H1;LARP6
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2674144808448205,0.7009079415019603,0.8511821974965229,1.0,1.0,5/35,16.15%,TRDMT1;TRPT1;TRMT5;GATB;ELAC2
prerank,phospholipase activity (GO:0004620),0.24574255883216434,0.7005563295533717,0.8929471032745592,1.0,1.0,6/67,8.86%,PITPNM3;PLCB4;SMPDL3A;PNPLA6;ABHD6;GDPD1
prerank,neuropeptide binding (GO:0042923),0.3029798009386096,0.7003751365604801,0.8280254777070064,1.0,1.0,3/18,20.95%,MC4R;GPR149;SORL1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.24146392042213125,0.6991479917076916,0.8985507246376812,1.0,1.0,17/74,17.77%,PIK3C2A;IPPK;IDNK;PGM2L1;TRPT1;RFK;DGKH;PIK3C3;NMRK1;PIK3CB;PAPSS1;PANK3;AGK;DGKI;GK5;DOLK;PIK3C2B
prerank,protein phosphatase activator activity (GO:0072542),-0.2723458163892599,-0.6940234163917611,0.8685567010309279,0.9786891380000128,1.0,3/13,10.41%,CALM2;IGFBP3;B3GAT3
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2646338697567443,0.6893953037596905,0.8746518105849582,1.0,1.0,5/33,10.29%,RNF125;RNF185;ARIH1;SIAH2;RNF144B
prerank,chemokine binding (GO:0019956),0.27296531478148506,0.687165965805687,0.8577405857740585,1.0,1.0,4/30,14.18%,CCR1;HMGB1;CX3CR1;CXCR4
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.23110974207104973,-0.6867343224338571,0.8963414634146342,0.9812780148108547,1.0,8/25,24.65%,PARP8;SIRT3;ART3;SIRT2;PARP6;PARP1;PARP3;PARP2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.28338157576694273,-0.6861859737127398,0.8709677419354839,0.9770607551327222,1.0,6/12,23.04%,TENT5A;TENT4B;TUT1;TENT5D;PAPOLB;PAPOLA
prerank,tRNA binding (GO:0000049),-0.2000375692949246,-0.6842538389629745,0.9541666666666667,0.9742000707574198,1.0,11/43,16.97%,NEMF;SSB;TERT;TRMT9B;AIMP1;EIF2AK4;RPUSD4;DALRD3;ELP5;IGHMBP2;PTCD1
prerank,acetyltransferase activity (GO:0016407),0.27044709234708286,0.6831409855110927,0.8841642228739003,1.0,1.0,2/31,5.31%,SATL1;LCAT
prerank,inward rectifier potassium channel activity (GO:0005242),-0.23215480100866084,-0.6817838971539015,0.9129129129129129,0.9717409027216583,1.0,7/24,22.39%,ABCC9;KCNJ13;KCNJ2;KCNJ8;KCNJ15;KCNK1;KCNJ10
prerank,damaged DNA binding (GO:0003684),0.2574690462927085,0.6814952876932735,0.8873994638069705,1.0,1.0,9/44,15.27%,RBBP8;APEX1;FEN1;HMGB1;HMGB2;ERCC4;RAD1;RAD18;XPC
prerank,single-stranded DNA binding (GO:0003697),0.227698336776484,0.6814732159794192,0.9315230224321134,1.0,1.0,17/93,16.11%,RBBP8;SSBP1;RTF1;PURA;POLR2G;HMGB1;DHX9;STN1;POLR2D;NUP35;POLA1;PCBP1;HMGB2;ERCC4;RAD51D;XPC;SPRTN
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.20801336596018494,0.6804948000233966,0.9673340358271865,1.0,1.0,33/232,15.22%,TRIM14;ZNRF1;TRIM69;CBL;HERC2;TRIM11;TRIM6;RNF38;RNF125;RNF185;ARIH1;CUL3;UBE2D1;TRIM24;WWP1;UBE3A;SIAH2;RNF115;ZNRF3;RNF128;RBX1;TRIM25;RNF144B;TRIM17;NEDD4L;DTX3L;SMURF1;FBXO2;UBE3B;UBE2D3;NHLRC1;TRIM2;IRF2BP1
prerank,phospholipid transfer activity (GO:0120014),0.2847790071579904,0.6797897858490205,0.852359208523592,1.0,1.0,4/21,8.91%,PLTP;GLTP;CERT1;PITPNA
prerank,palmitoyltransferase activity (GO:0016409),0.2710241976373582,0.6789351130930129,0.8764044943820225,1.0,1.0,10/28,30.66%,ZDHHC22;ZDHHC14;ZDHHC5;ZDHHC23;ZDHHC13;GLUL;ZDHHC15;GOLGA7;ZDHHC20;ZDHHC7
prerank,acyl-CoA hydrolase activity (GO:0047617),0.29894606767940807,0.6786006671614702,0.8330757341576507,1.0,1.0,2/17,9.79%,PPT1;ACOT13
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3185612955872199,0.6781136926376701,0.8633333333333333,1.0,1.0,11/11,68.17%,HCN1;KCNA10;CNGA1;CNGB1;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4;HCN2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.31368281438570905,0.6767610957496449,0.8291873963515755,1.0,1.0,2/11,9.85%,UBE4A;RBX1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.32335373439426196,0.6765800124044571,0.8327526132404182,1.0,1.0,3/10,16.69%,ANKRD13A;LAPTM5;DAXX
prerank,voltage-gated sodium channel activity (GO:0005248),-0.23166181957345533,-0.675969453849072,0.8961424332344213,0.9725316817824586,1.0,3/22,6.57%,SCN7A;SCN2A;CACNA1G
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.22999375770955585,0.6743968231596508,0.9339853300733496,1.0,1.0,18/75,24.04%,ABCC4;GFUS;LDHC;GLYR1;ADH5;LDHD;LDHAL6B;ME3;HADHB;CBR1;KCNAB1;HADH;HADHA;KCNAB2;HSD17B4;RDH12;RDH11;AKR1B10
prerank,phosphatidate phosphatase activity (GO:0008195),0.3090197247102221,0.6742179317582462,0.84472049689441,1.0,1.0,3/13,15.75%,PLPP1;PLPP4;PLPPR1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.259276571540215,-0.6732653547502964,0.8891891891891892,0.9703991738910152,1.0,4/15,16.60%,SH3PXD2B;PLA2G4A;PLEKHF1;JPH2
prerank,sequence-specific mRNA binding (GO:1990825),0.3287557873269567,0.6687826220385428,0.8517887563884157,1.0,1.0,2/10,9.69%,ETF1;DHX9
prerank,ATPase activator activity (GO:0001671),0.2824359019056734,0.6626367686989716,0.8847926267281107,1.0,1.0,6/20,20.39%,MYBPC3;DNAJB6;AHSA1;TOR1AIP2;DNAJC10;DNAJA1
prerank,voltage-gated anion channel activity (GO:0008308),0.2925698723079421,0.6604496785787061,0.8552631578947368,1.0,1.0,5/15,19.26%,ANO6;CLCN3;CLCN1;VDAC1;VDAC3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2722425614520404,0.6594326295703272,0.8755490483162518,1.0,1.0,1/24,2.53%,ZDHHC22
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.2565680461277722,-0.6572862044024151,0.8801089918256131,0.9796309553331493,1.0,2/14,18.64%,DHRS3;AKR1A1
prerank,acylglycerol lipase activity (GO:0047372),0.3106842559193222,0.6572614345657104,0.8665511265164645,1.0,1.0,3/11,23.64%,ABHD6;ABHD2;MGLL
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.27663783107084483,0.6553773458681944,0.8784773060029283,1.0,1.0,2/21,11.97%,GRIA1;GRM5
prerank,MAP kinase kinase activity (GO:0004708),0.28987120296768315,0.6548357532350341,0.8599348534201955,1.0,1.0,7/15,26.35%,LRRK2;MAPK14;MAP2K1;MAPKAPK5;MAP3K9;MAP2K4;MAPKAPK3
prerank,transcription coregulator binding (GO:0001221),0.23475069125222917,0.6533242377714413,0.925531914893617,1.0,1.0,10/50,18.45%,LMO2;ZBTB16;NR1D1;CHD6;CTBP2;CTNNB1;ESR1;CNOT2;SMAD4;RELA
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.2791742307590547,0.6528758124932109,0.8829113924050633,1.0,1.0,4/21,11.13%,CHRAC1;POLK;POLA1;POLB
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.30934865187947824,0.6520977439349976,0.8659127625201939,1.0,1.0,1/11,6.07%,APEX1
prerank,N-methyltransferase activity (GO:0008170),0.27936102178235755,0.649564499475736,0.8974763406940063,1.0,1.0,7/20,20.57%,METTL5;SETD3;TFB2M;METTL18;TRMT1L;GNMT;TRMT1
prerank,microtubule motor activity (GO:0003777),-0.1833978274546892,-0.6448018955405357,0.9833333333333333,0.9842946986887254,1.0,27/51,36.24%,KIF3C;KIF21A;KIF13B;KIF13A;SMC3;DYNLRB1;KIF9;KIF3A;KIF7;KIF5C;KIF11;KIF5B;KIF21B;CENPE;KIF1C;KIF6;KIF27;KIF18B;KIFC1;KIF4A;KIF22;KIF14;KIF1B;KIFC3;DYNC1I1;KIF19;DNAH17
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3054883880971475,0.6366296112744813,0.8683760683760684,1.0,1.0,1/11,5.88%,ARG1
prerank,ribosome binding (GO:0043022),0.23293864276890056,0.6359326287912788,0.9403183023872679,1.0,1.0,11/46,18.15%,ZC3H12A;ETF1;BAG6;EEF2;EIF6;EIF2A;EIF2S1;RACK1;EFL1;CCDC47;SRP19
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.22510417484443354,0.6307196668967845,0.9591315453384419,1.0,1.0,16/57,23.35%,NDUFS4;NDUFA12;NDUFB5;COX5A;NDUFB7;CYB561A3;UQCRFS1;CYBRD1;UQCRC1;COX15;NDUFB4;COX6A1;CYB5A;NDUFA9;NDUFV1;NDUFC1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.2636041686130299,-0.630376021115443,0.9009009009009009,0.9898931990756564,1.0,3/10,14.40%,ECHDC3;EHHADH;ECHDC2
prerank,solute:sodium symporter activity (GO:0015370),0.2529353492329992,0.6286959173059891,0.9194029850746268,1.0,1.0,2/27,9.15%,SLC5A10;SLC4A9
prerank,CCR chemokine receptor binding (GO:0048020),-0.20081310751563355,-0.6259205477356565,0.9556962025316456,0.9881623557041037,1.0,19/28,51.37%,CNIH4;CCL25;CCL19;CCR2;CCL2;CCL14;CCRL2;CX3CL1;CCL5;CCL8;MSMP;CCL7;DEFB130A;CCL1;CCL3;CCL11;CCL13;DEFB1;CXCL13
prerank,O-methyltransferase activity (GO:0008171),-0.26948182271171006,-0.6173365218683947,0.9371859296482412,0.9893254740712552,1.0,5/10,28.10%,CMTR1;ASMT;BCDIN3D;COMT;CMTR2
prerank,single-stranded DNA helicase activity (GO:0017116),0.2633204651435893,0.6168941255307764,0.9068702290076336,1.0,1.0,3/19,15.54%,WRNIP1;DHX9;RFC2
prerank,cytochrome-c oxidase activity (GO:0004129),0.2761578625682994,0.6168036118242927,0.8858954041204438,1.0,1.0,4/15,20.76%,COX5A;COX15;COX6A1;CYB5A
prerank,Hsp70 protein binding (GO:0030544),0.24178898191220993,0.6155496090058401,0.9351724137931035,1.0,1.0,7/31,20.39%,NOD2;DNAJC2;MVD;PPID;DNAJC10;ERN1;DNAJA1
prerank,DNA polymerase activity (GO:0034061),0.25888114133283413,0.6095906953777551,0.9278996865203761,1.0,1.0,4/22,11.13%,CHRAC1;POLK;POLA1;POLB
prerank,telomerase RNA binding (GO:0070034),0.25404969850624,0.6084871944649256,0.9258698940998488,1.0,1.0,10/22,29.25%,DKC1;NHP2;XRN1;SMG7;EXOSC10;DHX36;WRAP53;SMG5;HNRNPC;NOP10
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.28092629067605945,0.6051487065380361,0.9125412541254125,1.0,1.0,2/13,8.88%,ENDOV;FEN1
prerank,cardiolipin binding (GO:1901612),0.2963522026656763,0.6051143520283329,0.89198606271777,1.0,1.0,4/10,28.25%,UQCC3;MME;STOML2;GSDMD
prerank,ferrous iron binding (GO:0008198),-0.21281071672906043,-0.603701470850802,0.9481268011527377,0.9923244556413091,1.0,4/21,14.76%,EGLN3;FTO;TET2;FXN
prerank,exopeptidase activity (GO:0008238),0.2211579785837633,0.6012868855880417,0.9535809018567639,1.0,1.0,14/50,23.40%,ACE;DPP6;DPP10;METAP2;CPM;LAP3;XPNPEP3;DPP8;CTSH;LNPEP;ERAP1;FOLH1;MME;NUDT16
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2514355203182306,-0.5962537477503629,0.9336609336609336,0.9915470964347506,1.0,2/11,6.57%,HNRNPA2B1;RAD50
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.20576457586918928,0.5960538228759147,0.9779141104294479,1.0,1.0,14/69,19.12%,CERS4;GLYAT;LPCAT4;NMT1;CERS6;CERS5;LPCAT3;MOGAT1;LIPT1;ZDHHC14;ZDHHC5;SOAT1;PLAAT3;ELP3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.28789536568712515,0.5957986053964196,0.901294498381877,1.0,1.0,4/11,24.04%,RDH14;RDH12;RDH11;AKR1B10
prerank,muscle alpha-actinin binding (GO:0051371),0.2649109120998143,0.5944073565921447,0.9329073482428115,1.0,1.0,4/15,22.38%,PDLIM5;MYPN;PDLIM1;PRICKLE4
prerank,chemokine receptor binding (GO:0042379),-0.18122928569609342,-0.5941849839638746,0.9852941176470589,0.987986318739677,1.0,23/35,51.47%,CXCL16;CCL25;CKLF;CCL19;CXCL12;CCL2;CCL14;CCL28;CCRL2;CX3CL1;CCL5;PF4;PPBP;CCL8;CXCL5;CXCL1;CCL7;CCL1;CCL3;CCL11;CCL13;CXCL13;CXCL2
prerank,neuropeptide receptor activity (GO:0008188),0.2305732875857721,0.5893254145588012,0.9531914893617022,1.0,1.0,3/29,10.88%,GPR143;GAL;NPY5R
prerank,methyl-CpG binding (GO:0008327),-0.20242081639566323,-0.5834379982528635,0.9707602339181286,0.9886581953047314,1.0,8/22,29.43%,MECP2;CXXC5;TET1;MBD3;ZBTB33;WDR77;ZCWPW1;ZBTB38
prerank,ribosomal small subunit binding (GO:0043024),0.2524328544122076,0.5826702716023504,0.9301587301587302,1.0,1.0,3/17,15.32%,EIF1;NPM1;MTIF2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.26254959516903764,0.5820056271555257,0.9215070643642073,1.0,1.0,6/14,23.50%,ETFDH;ISCA2;NUBPL;RSAD2;RSAD1;IREB2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.24744109251703195,0.5819957580060848,0.9335347432024169,1.0,1.0,2/21,10.59%,P2RX7;GRIK2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.2587423367084222,0.5772767206315575,0.9481361426256077,1.0,1.0,3/14,17.06%,RPP38;ELAC2;POP1
prerank,serine-type endopeptidase activity (GO:0004252),0.19821762750430622,0.5753425027601197,0.9876543209876543,1.0,1.0,6/80,11.70%,PRSS53;PCSK5;RHBDD1;FURIN;PROC;PIK3IP1
prerank,endoribonuclease activity (GO:0004521),0.22505597066578636,0.5751625855383214,0.9573002754820936,1.0,1.0,8/32,19.83%,INTS11;ENDOV;ZC3H12A;EXOG;NOB1;KHNYN;ERN1;CPSF3
prerank,snoRNA binding (GO:0030515),0.2268121026609949,0.5715419759468089,0.9692982456140351,1.0,1.0,8/30,25.04%,DHX37;DKC1;NHP2;DDX21;RRP9;IMP4;NUDT16;NUDT16L1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.25842889449396145,0.5663398729294605,0.9401294498381877,1.0,1.0,4/15,23.25%,P2RX7;P2RY1;GPR34;P2RY12
prerank,methyltransferase activity (GO:0008168),0.20928755656113374,0.5659204859177066,0.9813333333333333,1.0,1.0,10/46,20.54%,COMTD1;MRM2;COQ3;GAMT;ARMT1;COQ5;FTSJ3;NSUN4;METTL4;LCMT1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.24008857116399124,-0.5637573753118461,0.9514066496163683,0.9924673273096231,1.0,5/10,33.50%,KAT2B;CDKN1A;CDKN2C;INCA1;CDKN2B
prerank,nucleotidase activity (GO:0008252),0.25306369579343485,0.5604303655729518,0.9472,1.0,1.0,5/15,21.92%,BPNT1;NT5C3B;NT5C2;NT5C;NT5C3A
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2646412654572846,0.560371568665765,0.92573402417962,0.9986242471090625,1.0,11/11,73.55%,PRMT7;PRMT5;FBXO11;PRMT2;PRMT6;CARM1;NDUFAF7;PRMT3;PRMT1;PRMT9;PRMT8
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.26500698792938454,0.5505505698239757,0.9367720465890182,1.0,1.0,3/10,23.98%,CYBA;NCF2;NOX1
prerank,3'-5' DNA helicase activity (GO:0043138),0.24842222134298353,0.550097301360319,0.9498381877022654,0.9986190544668972,1.0,6/16,27.38%,DHX9;ASCC3;BLM;HELQ;WRN;NAV2
prerank,pseudouridine synthase activity (GO:0009982),0.25531916893602896,0.5492509530046827,0.936,0.9967844529137866,1.0,3/13,18.19%,DKC1;TRUB1;RPUSD2
prerank,peptide hormone receptor binding (GO:0051428),0.2520871257297095,0.5442093580281641,0.9634340222575517,0.9966889448566935,1.0,11/11,74.81%,PSMC5;PTHLH;UCN3;GPHA2;GHRH;GPHB5;UCN2;VIP;CCK;ADCYAP1;GNRH1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.20992021729646548,0.543181899336934,0.9808743169398907,0.994901144677658,1.0,6/34,19.81%,IQGAP1;IRGM;CALM3;RICTOR;MAP2K1;CAB39
prerank,CXCR chemokine receptor binding (GO:0045236),-0.222563814682872,-0.5407681421074959,0.961038961038961,0.9956278850443627,1.0,8/11,51.47%,YARS1;CXCL12;PF4;PPBP;CXCL5;CXCL1;CXCL13;CXCL2
prerank,endonuclease activity (GO:0004519),0.19419860117364504,0.5310135769326202,0.9893333333333333,0.9972374509901949,1.0,11/49,19.93%,APEX1;INTS11;ZC3H12A;FEN1;ERCC4;EXOG;NOB1;KHNYN;ERN1;CPSF3;ANG
prerank,kinase inhibitor activity (GO:0019210),0.20510767698812063,0.5235855578953684,0.9831697054698457,0.9975313055074483,1.0,7/33,16.22%,WARS1;SMCR8;NPM1;RHOH;SPRY4;SH3BP5L;NCK1
prerank,acetylcholine receptor activity (GO:0015464),0.20770005810545222,0.5037196934570329,0.967551622418879,1.0,1.0,2/22,15.67%,CHRM3;HRH3
prerank,ribonuclease P RNA binding (GO:0033204),0.24145617099956446,0.4991404076508698,0.9813559322033898,1.0,1.0,2/10,17.06%,RPP38;POP1
prerank,NAD+ binding (GO:0070403),0.22679370432236357,0.49401726806949225,0.9650959860383944,0.9993730801148742,1.0,3/12,19.21%,GLUD1;HADH;ZC3HAV1
prerank,ribonuclease P activity (GO:0004526),0.22371716895492302,0.474101174614419,0.9918433931484503,1.0,1.0,2/11,17.06%,RPP38;POP1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.20588315493808024,-0.46518387282676804,0.9832935560859188,1.0,1.0,4/10,29.22%,CYLD;STAMBPL1;TNFAIP3;DESI2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.19483819528854704,-0.46385258988455585,0.9951100244498777,1.0,1.0,1/11,4.30%,NUDT4
prerank,serine-type peptidase activity (GO:0008236),0.15557630006583129,0.4629016624649024,1.0,1.0,1.0,5/96,8.54%,PRSS53;PCSK5;RHBDD1;FURIN;PROC
prerank,CoA hydrolase activity (GO:0016289),-0.17445540329347442,-0.4614205319930666,0.989010989010989,0.9989543780906714,1.0,2/16,16.19%,ACOT11;ACOT6
prerank,neuropeptide hormone activity (GO:0005184),-0.15558272780161114,-0.44875378741885197,0.9911242603550295,0.9959667419978196,1.0,7/22,30.53%,PPY;ADCYAP1;CCK;SPX;NPY;NPFF;PNOC
prerank,5'-nucleotidase activity (GO:0008253),0.19729389110333567,0.4255923578412471,0.9869281045751634,1.0,1.0,4/13,21.92%,NT5C3B;NT5C2;NT5C;NT5C3A
prerank,phosphatase activator activity (GO:0019211),0.1903119534896169,0.42186554591271375,0.9951060358890701,1.0,1.0,5/14,26.43%,PPP2R5C;CALM3;PPP2R5E;PPP1R15A;CALM1
prerank,U6 snRNA binding (GO:0017070),0.17404665766222746,0.3869913911902685,0.993431855500821,1.0,1.0,3/14,19.09%,PRPF4;DDX39B;LSM2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.16731072316652768,0.3791689212375213,0.9968454258675079,1.0,1.0,2/16,15.09%,CD38;SARM1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.1700453877213082,0.376945892605135,0.9966777408637874,0.9986716309396849,1.0,2/14,15.12%,CYBA;NCF2
